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                                    INTRODUCTION 
The Tamil speaking southern peninsular region  undertook a systematic study of 
the nature and its elements from which they had developed a highly systematized 
medicine which is now known “Siddha Medicine”. Siddha system is well founded under 
the basic principles of nature and its elements. The Siddha system originated from 18 
Siddhars headed by 'Agathiyar'. 
Prevention and Treatment are the basic aim of the siddha system of medicine, 
where as the Siddha system has in addition to the transcendental motivation of that rigor 
to be called the immortality is the body. Siddha System is a vast and unique system 
which defines health as a perfect state of Physical, Psychological, Social and Spiritual 
well being of an individual. The system not only deals with medicine, but with 
spirituality, righteous way of living, rejuvenation and its main aim is attainment of 
perfection. This is clearly mentioned in the following verse of Thirumanthiram; 
“clk;ghh; mopapy; capuhh; mopth; 
jplk;glnka;Qhdk; NruTk; khl;lhh; 
clk;igtsh;f;Fk; cghak; mwpe;Nj 
clk;igtsh;j;Njd; caph; tsh;j;NjNd” 
    - jpUke;jpuk; (724) 
Siddha system of medicine is mainly based on the Thrithodam theory. The 
thrithodam namely Vatham, Pitham and Kabam circulate in the bodily system in 
different proportions which helps to maintain the vitality of the body. When these vital 
humours become abnormal or when their mutual harmony is disturbed it leads to ill-
health. 
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Siddha system is very effective in chronic disorders especially skin diseases and 
rhematological problems. Siddha system elaborately deals with 18 types of kuttam and 
their treatments. Among these, Padarthamarai (Pundareega kuttam) is one of the 
common disease which affects the human beings. That's way. the author has selected the 
disease Padarthamarai for his dissertation with the following trial medicines.  
PARANGICHAKKAI CHOORANAM -  INTERNAL  
NEERADIMUTHU  PASAI   -  EXTERNAL 
Padar Thamarai is one of the commonest skin problems and it needs special 
attention because of its troublesome itching and recurrence. According to the following 
verse it is known that the disease is mainly occurs due to the disturbance of Vatham 
humour,   
“thjkyhJNkdpnflhJ” 
                    -  Njiuah; 
Siddhar Yugi, in his text clearly charted out the 18 types of  kuttam under  the 
broad heading of Kuttam. In modern science the symptoms and signs of Padar thamarai 
(Pundareega kuttam) is correlated with Tinea. 
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AIM AND OBJECTIVES 
 
 The main objective of this study is to highlight the therapeutic efficacy of siddha 
drugs by conducting a clinical trial on disease ‘Padar thamarai’ with  ‘Parangichakkai 
Chooranam’ as internal medicine and ‘Neeradimuthu  Pasai’ as external medicine to the 
scientific community and the sub objectives of my study are: 
Ø To collect various literatures and modern text books as literal evidences 
regarding the disease PADAR THAMARAI 
Ø To expose the unique diagnostic methods mentioned by Siddhars 
Ø To know the extent of correlation of the disease with age, sex, socio-economical 
status, habit, family history and Paruva kaalam (Seasons). 
Ø To have a complete study of a disease Padar Thamarai under the heading of 
Mukkutram, Udalkattugal, Enn vagai thervu etc., in order to evaluate the 
pathogenesis, pathology of Padar Thamarai. 
Ø To have a detail clinical investigation and to utilize the possible diagnostic tools 
in the confirmation of the diagnosis and prognosis of the disease. 
Ø To analyse the trial drugs by biochemical studies.  
Ø To study the factors like diet, land, climatic condition and personal hygiene in 
relation with Padarthamarai. 
Ø To make an awareness among the people about the prevention of the disease.  
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SIDDHA ASPECTS 
              PADAR THAMARAI  
 
1. rpwg;G kUj;Jtk; Ehypd; $w;Wg;gb 
· glh;jhkiuNehahdJ Rj;jkhf Nja;j;Jf; Fspf;fhjthplk; ,Lg;G> 
njhil> ,Lf;F Kjypa ,lq;fspy; ntFthf cz;lhfpf; fhZtJ 
xU tif Njhy; NehahFk;. 
· NkYk; Kfj;ij kOg;gpf; nfhs;Sk; Mz;fSf;F Kfj;jpy; 
cz;lhfpwJ. njhw;wf; $bait> mjpf eikr;ry; ,Uf;Fk.; 
· MilfshYk;> Kfk; kOg;Gk; fj;jpfhsYk; guTfpd;wd. Neha; fz;l 
,lk; rpte;jhtJ fUik epwKldhtJ> tuk;G fl;b vhpr;rYld; 
fhZk;> nrhwpar; nra;Ak;> nrhwpe;jhy; fhe;jYz;lhFk;. rpy gilfs; 
jbj;j gidkug;gl;il Nghy RuRug;ghf ,Uf;Fk;; 
 
2. T. V. rhk;grptk; gps;isatHfspd; $w;Wg;gb 
· Characterized by eruption of inflamed vesicles or scales spreading on the 
body as an orbicular lotus leaf – ringworm infection. 
· The affected area shows reddish brown or mild black coloured patches with 
well defined specified margins burning sensation with severe itching. 
            The meaining of Padar thamarai is mentioned as follows: 
 glh;   - Jd;gk;> Neha;> glUjy; 
 jhkiu  - fkyk;> Gz;luPfk; 
· It is a kind of skin disease that spreads like ring worm. 
 
3. rpfpr;rhuj;e jPgk; 2k; ghfk; itj;jparpe;jhkzp Ehypd; $w;Wg;gb 
glh;jhkiuahdJ Njfj;jpy; gy &gq;fshf rpte;J eikr;ry; 
vLf;Fk;. tpah;f;FUf;fs; Nghyj; Njhd;wp jpdntLf;Fk;. ehSf;F ehs; 
guTk;. 
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4. jd;te;jphp $w;Wg;gb 
“Mbfdj;njhpe;Jr; nrg;ghahuj;jpr; rpe;JfSz;lha;j; 
jplg;glf; fgpiy tz;zQ; nrhpe;J ePh;nghrpe;J Gz;zhy; 
,bg;gJ nghWj;J NjhW kpQ;rpa tpuzq;fhzpy; 
klg;gpb aida khNj typjU Gz;lhPfk;” 
                                       - jd;te;jphp. 
Ø The base or margin of patches are thickened 
Ø Burning Sensation is present 
Ø Sometimes they are red in colour 
Ø Oozing is present 
Ø The patches sometimes become lacerated or vesiculo papule 
5. khd;KUf;fpak; Ehypd; $w;Wg;gb 
               “eLtd; ntSj;jy; mUF rptj;jy; 
 jpdT Njhd;wy; ntk;ky; Nehjy; 
jhkiu Kl;Nghy; nrk;Kis guty; 
 jbj;jy; nfhOj;jy; FUjp rPnohOfy; 
tpiutpY ile;J Gz;gly; vDkpit 
  jhkiu njhOtpd; Fwpnad nkhopg” 
- khd;KUf;fpak; 
Ø The patches are white in the center, and red in the margin 
Ø Burning sensation followed by pain is present in the patches 
Ø The patches spread like the thorn of the lotus flower 
Ø The patches are thickened 
Ø Sometimes blood and pus oozed from the affected patches 
 
AETIOLOGY: 
 1. jpU%yhpd; $w;Wg;gb 
“tpahjpAz; %thW tpsq;fpa Fl;lq;Nfs; 
Rahjp fpue;jp Rod; Nkfj;jhyhWk; 
gahjp kz;Zsg;gy tz;bdh nyl;Lk; 
epahjp GOehyha; epd;wjpf; Fl;lNk” 
  
6 
 
· Six types of kuttam are caused by kiranthi and megam.  
· Eight types are caused by insects in the soil .  
· Four types are caused by worms.  
 2. FUehb $w;Wg;gb> 
1 “fpUkpahy; te;j Njhlk; ngUfTz;L 
 Nfl;fpyjd; gphpTjidf; fpukkhf 
 nghUkp tUk; thAnty;yhq; fpUkpahNy 
 GOf;fb Nghy; fhZkJ fpUkpahNy 
 nrUkptUk; gTj;jpuq;fs; fpUkpahNy 
 Njfkjpy; nrhhpf; Fl;lk; fpUkpahNy 
 JUkp tUQ; RNuhzpjq; fpUkpahNy 
 #l;rKld; fphpirg;ghy; njhopy; nra;tPNu” 
2) “Fl;lkJtpl fug;ghd; tplePh;#iy 
 RNuhzpjj;jhy; jhJnfl;Lj; jbg;Gz;lhFk; 
 kl;lwNk fpUkpnrd;W kUTk; NghJ 
 tifaha;f; fpUkpAl tplePh; nrd;W 
 Fl;lKld; Njfnky;yhk; gwf;Fk; NghJ 
 FopFopaha;f; fpUkpapdPh;f; nfhs;Sk;Gs;sp 
 jl;lwNt fpUkpAl ePuhy; te;j  
 rfy Fl;lk; tplfug;ghd; rhw;wyhNk” 
The above two verses indicate that skin diseases are caused by micro    
organisms and worms infestations  
  3. mfj;jpaH fd;k fhz;lj;jpd; gb> 
   “Nrh;e;j Fl;lnkhL Fiw Neha;fs; te;j 
             Nrjpfs; kyuhj mUk;G nfha;jy; 
             jhhpe;j rptnre;J tijfs; nra;jy; 
   jha;je;ij kdJnehe;J Nuhfe;jhNd 
             jhndd;w nja;tUj; jidapopj;jy; 
           rhh;thd nghpNahh;fs; jikg;gopj;jy; 
   fhndd;w ee;jtdk; G+Q;nrbfs; ntl;ly; 
   fUkklh rhPuj;jpw; fhRNghNy 
   A+ndd;w Tlk;ngy;yhk; nghl;Lg; nghl;lh 
   Aly; ntSj;Jf; FiwNehah AjpuQ;rpe;Jk;” 
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    4. khd;KUf;fpaKk; gpd;tUkhW gfHfpd;wJ> 
          “kWj;j TzTfs; kpFjpAz;zy; 
           ,af;f klf;fy; fUePh;nrWj;jy; 
           kWg;G Kjypa ntOr;rpfs; jLj;jy; 
           kPd; Gyhy; vs;S kpifg;glTz;zy; 
           gfy; kpf Japyy; ,uT Japyhik” 
    5. jd;te;jphp: 
“mwptpd;wp tpghpjQ; Nruhfhuk; Grpf;fyhYk; 
 Jiwapd;wp njhlhj njhd;iw njhl;lit Grpf;fyhYk; 
 Fiwnfhz;l eprpj;j kq;if Fykq;if aLf;fyhYk; 
 epiwnfhz;l nghpNahh; jk;ik epe;jpj;J NgryhYk;” 
“epe;jpj;J Gwj;jpahw; Nrhkepiy nflg; gphpf;fyhYk; 
 ce;jpj;J G+h;th n[d;khe;jpu ghtj;jhYk; 
 re;jpf;f fw;Gkhjh; jq;fis fUjyhYk; 
 njhe;jpj;j Fl;l Nuhfk; njhLf;F nkd;Wiuj;Njhh; Kd;Ndhh;” 
  6. A+fpKdp $w;Wg;gb> 
 “tpsk;gNt kpFe;j c\;ze;jd;dhYk; 
  kpFe;j rPjsj;jhY kow;rpahYk; 
 tsk;gNt ke;jj;jhy; the;jpahYk; 
  kfj;jhd ngz;NzhL kUtyhYk; 
  fpsk;gNt fpNyrq;fs; kpFjyhYk; 
  nfbahd th;f;fq; fsiljyhYk; 
  jsk;gNt kapUfph;fs; jtpLkz;fs; 
  rhjj;jpw; gUfyhy; kpFq;Fl;lk;” 
 “Fl;le;jhd; gjpndl;L tuNt njd;dpw 
  FUepe;ij> rptepe;ij kiwNahh; epe;ij 
  jpl;le;jhd; Njtijj; J}\izf; FNuhjk; 
  ntg;gyhw; wp&lyhw; gujhuj;ij 
  ml;le;jhdh irahy ilf; fyj;ij 
  mgfhpj;j mfjp guNjrp jd;id 
  tl;le;jhd; itjyhw; fw;gopg;ghy; 
  te;jpLNk gjpndl;L Fl;le;jhNd”    
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· Excessive heat and cold, laziness, excessive sleep in day time, unbridled 
sexual indulgence, robbery etc.These habits are supposed to be the factors 
which lowers the immune mechanism of the body (iyarkkai vanmai) and 
makes the body liable to diseases.  
· Excessive intake of food items which are hard to digest, imbalanced food 
and vomiting, frequent intake of food mixed with stone and hair.  
· Prolonged mental depression, intention to spoil others, greedy, abusing god 
and noble people, neglecting orphans and beggars, cursing the elders and 
soon. These were the causes mentioned by Yugi.  
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Types of kuttam: 
According to Yugi Vaithiya Chinthamani – 800, kuttam has been classified into 
18 types.  
          “Kj;jhq; Fl;le;jhd; gjpndl;Lf;Fk; 
Kdpahd A+fp ehd; nrhy;yf; Nfsha; 
Gj;jhFk; Gz;lhpff Fl;lj;NjhL 
nghUfpd;w tpw;Nghlff; Fl;lkhFk; 
gj;jhFk; ghkf;Fl;lk;> fr;rh;k Fl;lk; 
ghpthd fuzFl;lk;> rpFuFl;lk; 
fpj;jhFk; fpUl;bzf;Fl;lk;> mTJk;guf;Fl;lk;> 
nfbahd kz;lyFl;lKkh nkd;Nd 
Fl;lkhk; ghg; ghpr Fl;lnkhL 
Fbykhk; tprh;rPff; Fl;lkhFk; 
tl;lkhk; itahjp Fl;lnkhL 
kUtyhq; fPBg Fl;l rh;kjy 
jpl;lkhe; Njj;jpUf; Fl;lNkhL 
rpj;Jkh> Fl;lQ;r fhU Fl;le; 
JllkhQ; RNtjh\;le;> jd;ndhnlhf;fr;  
Rak;ghd gjpndl;L Fl;lkhr;Nr” 
          The eighteen types are:   
1. Pundareega kuttam.  
2. Virpodaga kuttam.  
3. Baama kuttam.   
4. Gajasaruma kuttam.  
5. Karna kuttam  
6. Siguram.  
7. Krishna kuttam.  
8. Avudhumbaram  
9. Mandala kuttam.  
10. Abarisa kuttam.  
11. Visarchika kuttam.  
12. Vibaathika kuttam.  
13. Kideeba kuttam.  
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14. Sarmathala kuttam.  
15. Thethru kuttam.  
16. Sithuma kuttam.  
17. Sathaaru kuttam.  
18. Swetha kuttam. 
A+fpKdptH $w;Wg;gb: 
              Gz;lhpf Fl;lk; 
“$LNk jhkiuapd; G+tpjo; Nghy; 
 Ftpe;JNk fWg;NghL ntSg;ghFk; 
NjLNk rptg;G gyth;zkhFk; 
 jpdTkpf thuhJ nrhidapw; gd;dPh; 
thLNk ma;apDw; gj;jpahfp 
 tUj;j kpfTz;lhfp NehTkhFk; 
NghLNk rhPuq;fs; Kfq;fs; fhJ 
 Gz;lhPff; Fl;lj;jpd; GJik jhNd” 
Ø Characterized by eruption of inflamed vesicles or scales spreading on the 
body as an orbicular lotus leaf.  
Ø Affected part becomes whitish, reddish or blackish in colour.  
Ø  Lesions are well defined with intense itching and burning sensation.  
Ø Borders are slightly elevated and spreading in nature.  
PROGNOSIS : 
 
 Pundareega kuttam is stated as curable type by Siddhar Dhanvantri Vaithiyam 
 According to the text ‘Yugi Vaithiya Chinthamani – 800’. 
“Fl;le;jhd; gjpndl;b yrhj;jpae;jhd; 
 $wf;Nfs; tpw; Nghlf ghkf; Fl;lk; 
fpl;le;jhd; fr rUkFl;l NkhL 
 fpUl;bz Fl;lk; TJk;gu Fl;le;jhDk; 
jpl;lkhe; jj;jpUf; Fl;lNkhL 
 nra; jPj;Jkh Fl;lq; fpBg Fl;lk; 
jl;le;jhd; kpFe;jr jhU Fl;lk; 
 rk;fpUl;bz Fl;lk; rhj;jpakh nkd;Nd” 
-   A+fp itj;jpa rpe;jhkzp 800 
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The following ten types are said to be curable. 
1. Virpodaga kuttam.  
2. Baama kuttam.  
3. Gajasaruma kuttam.  
4. Krishna kuttam.  
5. Avudhumbaram  
6. Kideeba kuttam.   
7. Sarmathala kuttam.  
8. Thethru kuttam.  
9. Sithuma kuttam.  
10. Sathaaru kuttam.  
According to the text ‘Dhanvantri Vaithiyam’: 
“G+z;ljj; JUtpfNshL rjhhpfk; Gz;lhPfe;j 
 jhz;L tpw;Nghlk;> ghkhTld;> rh;kjyk;> ntz;Fl;lq; 
cz;bU fhf> ee;jp> rpj;Jik ayr Fl;lk; 
 Ntz;ba tpahjpNahLk; gjpndhd;Wk; tphpj;Jf;fhNz” 
The following 11 types are stated as curable types of kuttam. 
1. Thethru kuttam  
2. Sathaaru kuttam.  
3. Pundareega kuttam.  
4. Virpotaka kuttam.  
5. Baama kuttam.  
6. Sarmathala kuttam.  
7. Kaaganandhi kuttam.  
8. Venkuttam.  
9. Sithuma kuttam.  
10. Alasa kuttam.  
11. Vipaathika kuttam  
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DIAGNOSIS: 
Diagnosis is based upon three main principles. They are;  
1. Poriyaal arithal (Inspection )  
2. Pulanaal arithal (Palpation)  
3. Vinathal (Interrogation)  
Physician‟s Pori and pulan are used as tools for examining the pori and 
pulan of the patient in arriving at a clinical diagnosis of the disease.   
Ennvagai thervugal (eight  diagnostic tools):  
            Siddhars have developed a unique method of diagnosing the disease is Ennvagai 
Thervugal. They are;  
1. Naadi (Pulse).  
2. Sparisam (Touch).  
3. Naa (Tongue).  
4. Niram (Colour).  
5. Mozhi (Voice).  
6. Vizhi (Eyes)  
7. Malam (Faeces)  
8. Moothiram (Urine)  
Clinical approch of Padar thamarai by Ennvagai Thervugal:  
1. NAADI (PULSE):  
 Among the three thodams vatham and pitham are mainly affected in Padar 
thamarai. Stress and strain will provoke the pitham which may affect the Prasaga pitham 
which is responsible for the nature of skin, its moisture and complex with erythematous 
skin lesions. Involvement of vatham may produce itching. Involvement of kabam, skin 
and its appendix are affected and there may be excessive formation of scales and 
deformity of nails in chronic stage 
I. According to Theraiyar:  
“thjkyhJ NkdpnflhJ” 
Vatham is considered as the main cause which affects the complexion of the skin 
and strength of our body.  
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II. According to Dhanvanthri:  
             The three thodams i.e. vatham, pitham, kabam get deranged and affect nerves, 
blood, hormones, muscles, skin and causes "Kuttam". This is mentioned in the 
following verse: 
          “Kd;dpa thjgpj;jr; rpNyj;Jkd %d;W kq;fk; 
            gpd;dpNa jhWf;fhAs;s euk;gpw; gpuNtrpj;J 
     kz;zpa ,uj;jk; jz;zPh; khq;fp\e; Njhy;nfLj;Nj 
     ad;dpa td;dq; fhZkhifahw; Fl;lNk” 
 
 III. According to Jeevarakshamirtham  
Due to high intake of food pitham increases and affects samanan, pithakabam, 
pithavatham, mukuttram. These affected kuttram individually or in combination, affect 
the body and blood and also affects the path of pithakabam and in turn affects urine and 
other wastes in our body and cause kuttam finally. The three thodams gets deranged and 
affect the skin, blood, muscles, bones etc and finally cause kuttam. Worms also take part 
in the cause of kuttam.  
Naadi nadai in padarthamarai 
The deranged three thodams in padarthamarai noi is manifested as increased 
kabha thodam and association of excessive heat with vatha thodam. 
2. SPARISAM (SENSE OF TOUCH):  
The features of warmth, chillness, dryness, roughness of the skin, oozing, 
sweating, tenderness, fissures, depigmentation changes in the skin, swelling, emaciation 
are examined by sparisam.  
In Padarthamarai, the skin becomes hyperpigmented, with well-defined borders 
with central clearing nature.  
3. NAA (TONGUE):  
Colour of the tongue, dryness, coated tongue, excessive salivation, redness, 
ulceration, fissure, pallor, yellowish discolouration, malignant outgrowth, taste 
variations, speech and deviation of the tongue, the conditions of the teeth and gums are 
to be noted.  
In Padarthamarai sometimes tongue may be noticed as flour coated tongue.  
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 4. NIRAM (COLOUR):  
Changes in the colour of the skin, teeth, eyes, nails, and lips due to mukkutra 
derangement are to be noticed, hypo or hyper pigmentation is also to be noted.  
In Padarthamarai, skin is hyper- pigmented, erythematous, macular, slightly 
raised, well defined lesions with centre clearing nature.  
5. MOZHI (VOICE):  
Examination of mozhi includes clarity of speech, speech disturbances, crying, 
high or low pitched voice, slurring or incoherent speech, scanning speech, talk 
associated with hallucination, undue argument, breathlessness, nasal voice or hoarseness 
of voice, wheezing etc., to be examined.  
In Pundareega kuttam, no change is seen in speech.  
 6. VIZHI (EYES):  
 The motor and sensory activities of eyes are to be noted. Also any abnormal 
7. MALAM (FAECES): 
Colour change indicating and mukkutram derangement, hyperemia, ulceration, 
bluish discolouration, response to pupil, pallor, protrusion, sunken eyes, and sharpness 
of vision, excessive lacrimation, angle of eyes, subconjuctival bleeding, visual 
disturbances are to be noted.  
In Padarthamarai, no change is seen regarding eyes. Colour, froth, consistency, 
quantity, odour, frequency, constipation, presence of mucus, blood and undigested 
matter in the stool are to be noticed In Padarthamarai, no change is seen regarding 
malam.   
8. MOOTHIRAM (URINE): 
            It is a special diagnostic method of Siddha. Determination of Neerkuri and 
Neikuri in moothiram were done.  
Neikuri:  
Collection of urine for neerkuri and neikuri examination:  
 Prior to the day of urine examination, the patient is instructed to take a balanced 
diet and quantities of food must be proportionate to his routine intake. The patient 
should have no disturbed sleep. After waking up in the morning, the first urine voided 
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will be collected in a clear wide mouthed glass container and is subjected to analysis of 
neerkuri and neikuri within 1 ½ hrs.  The specimen is kept open in a glass dish or china 
clay container. It is to be examined under direct sunlight without shaking the vessel. 
Drip one drop of gingelly oil on the surface and observe keenly the spreading pattern 
within few minutes and diagnosis is made as follows, 
Ø If the oil spreads like a snake – Vatha neer.  
Ø If the oil spreads like a ring – Pitha neer.  
Ø If the oil remains as such and if floats like a pearl – Kaba neer.  
Ø If the oil spreads like ring in the snake - Thontha neer.  
Ø If the oil spreads like snake in the ring - Thontha neer.  
Ø If the oil spreads like pearl in the snake - Thontha neer.  
Ø If the oil spreads like pearl in the ring - Thontha neer.  
In Padarthamarai, Thontha Neer was noted in most of the cases.  
“mUe;Jkhwp ujKk; mtpNuhjkha;  
m/fy; myh;jy; mfhyT+z; jtph;e;jow;  
Fw;wstUe;jp cwq;fp itfiw  
Mbfyrj; jhtpNa fhJ nga;  
njhU K$h;j;jf; fiyf;Fl;gLePhpd;  
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd”.  
“muntd ePz;bd; m/Nj thjk;  
Mop Nghy; gutpd; m/Nj gpj;jk;  
Kj;njhj;J epw;fpd; nkhoptnjd; fgNk  
mutpyhopAk; Mopapy; muTk;  
mutpd; Kj;Jk; Mopapy; Kj;Jk;  
Njhw;wpa njhe;j Njhlq;fshNk” 
Neerkuri:  
 Voided urine has to be examined, the following characters;  
Ø Niram (Colour)  
Ø Edai (Specific gravity)  
Ø Manam (Smell)  
Ø Nurai (Frothy nature)  
Ø Enjal (Quantity of urine voided).  
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“te;j ePh; fhp vil kzk; Eiu vQ;rnyd;  
 iwe;jpaYsit aiwFJ KiwNa” 
              Apart from these, the frequency of urination, abnormal constituents such as 
proteins, presence of blood, pus, renal calculus, crystals etc., also to be examined.  
               In Padar thamarai patients, straw or hey coloured urine is noticed. 
Udal Kattugal 
Human body is made up of 7 udal kattugal which are important for the structure 
and function of the body. In case of pundareega kuttam, among the seven udal kattugal 
(seven physical constituents) saaram and senneer are commonly affected.  
 LINE OF TREATMENT:  
In accordance with the Siddha system of medicine, certain basic principles are 
followed before starting the specific drug therapy. These principles are initially 
followed to balance the deranged kutrams i.e., vatham, pitham and kabam. They are 
purgation, vomiting, and application of drugs in the eyes to neutralize the deranged 
vatham, pitham and kabam respectively.  
1. Purgation: Virechana Boopathy Pills 2 (OD) in empty stomach.  
2. Aga Maruthuvam: Parangichakkai Chooranam -5 Gms; Twice a day with 
honey.  
3. Pura Maruthuvam: Neeradimuthu Pasai - For external application.  
4. Sirappu Maruthuvam: Patients are also advised to follow pranayamam, 
yogam and asanams for the speedy cure and prevention of recurrence.  
   a. Yogam: Yogam is a way of life, an integrated system of education, for the 
body, mind of inner spirit. Patients were advised to do yoga to bring down their stress 
and strain. Asanams which are advised to the patients were,  
1. Padmasanam  
2. Savasanam  
3. Gnayiru vanakkam (Surya Namaskkaram)  
These asanams helps to prevent and cure skin diseases. These techniques were 
very helpful in relieving the stress and strain of the patients.  
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           b. Pranayamam:  
It is a form of kayakalpa method and by practicing this, one can prevent many 
diseases. All the patients were advised to do the regular practice of  
1. Omkara pranayamam  
2. Sleeping pranayamam.  
  KAAPU (PREVENTION):  
Ø Take bath daily and avoid bathing in lake, pond.  
Ø Use warm water for bath.  
Ø  Use green gram powder or "Nalangu Maa" instead of soap for bath.  
Ø Wash in dresses with disinfectant solution and dry in direct sunlight.  
Ø Avoid stress and strain totally.  
Ø  Asked to wear fresh dry and cotton clothes.  
Ø Advised to trim the nails.  
Ø Use antiseptic lotion and padigi like astringent mixed water after shaving. 
PATHIYAM:  
“gj;jpaj;jpdhNy gyDz;lhFk; kUe;J  
gj;jpaq;fs; Nghdhy; gyd; NghFk; - gj;jpaj;jpy;  
gj;jpaNk ntw;wp jUk; gz;bjh;f;F Mjypdhy;  
gj;jpaNk cj;jpnad;W ghh;” 
      - Njiuah; ntz;gh 
  
During diseased condition and consumption of medicines, diet restrictions or 
pathiyam should be strictly followed. These are prescribed to normalize the deserved 
thodams and to potentiate the drugs.  
  ACCORDING TO PADHARTHA GUNA CHINTHAMANI:  
“ngUFQ; Nrhs kpWq;Fk; ngUq; fk;G  
tuF fhUld; thioapd; fhnahL  
ciunfhs; ghfw; nfspw;W kPd; cz;bby;  
tphptjha;f; fug;ghD kpFe;jNj” 
                      - gjhh;j;j Fzrpe;jhkzp 
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DIET:  
Ø Patient was strictly instructed to avoid all the non-vegetarian food items 
except goat’s meat.  
Ø  To avoid bitter substances like bitter guard , leaves of agathi and  
Ø Gingely oil, brinjal, jack fruit, maize, flat bean, great pumpkin.  
Ø Salt and tamarind restriction.  
KANMA NIVARTHY (EXPIATION)  
“NgW apsik ,d;gk; %g;G  
 gpzp rhf;fhL apitahWk; fUtpyikg;G” 
Kanmam occurs by birth itself. According to Agasthiyar Kanma Kandam - 300 
the kanma nivarthy can be attained by the following;  
1. Gardening  
2. Digging wells for common use.  
3. Constructing temples.  
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MODERN ASPECTS 
SKIN 
   The skin or cutis is very essential to life. The skin is anatomically and physiologically 
specialized boundary lamina. It is major organ of the body, forming about 8% of its total mass 
and having an area of between 1.2 to 2.2 m2. In total thickness ranges from about 1.5 to 4 mm. 
ANATOMY 
Skin covers the entire external surface of the body including the external auditory meatus 
and lateral aspect of tymphanic membrane. It is continuous with the mucosa of the alimentary, 
respiratory and urogenital tract at their respective orifices, where the specialized skin of 
mucocutaneous junction occurs; it also fuses with the conjunctiva at the lacrimal puncta. 
`Structurally skin is a complex and highly specialized as might be expected of the major 
interspace between the body and its environment. Microscopically it is formed as an intimate 
association between two distinct tissues; 
Keratinized stratified squamous epithelium superficially the "epidermis" and a deeper 
layer of moderately dense connective tissue, the "dermis".Because of this combination it is 
within limits a most effective barrier against microbial invasion and dehydration and against 
mechanical, chemical osmotic, thermal, photic damage. 
Epidermis 
The epidermis is formed of non-vascular stratified epithelium. Its usual thickness is 
between 0.07 mm and 0.12 mm. The epidermis is mainly two divisible into two main systems; 
they are keratinising (or) malpighian system (keratinocytes), which forms the bulk, and the 
pigmentary system (melanocytes) that produces the pigment. There are five layers in the 
epidermis. 
1. Stratum Germinativum (or) Stratum Basale  
This is the deepest portion of the epidermis and is composed of columnar cells placed 
perpendicular to the skin surface. The whole of the epidermis germinates from this stratum, 
hence the name stratum germinativum. 
 2. Stratum malpighii (or) The Prickle Cell Layer 
It is superficial to the basal cell layer, and is composed of several layers of polyhydral 
cells connected to each other by intercellular bridges. 
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3. Stratum Granulosum 
It is superficial to the stratum malpighii. It is composed of flat, fusiform cells that are one 
to three layers thick. These cells contain irregular, granules of keratohyalin and lysosomal 
enzymes and cystine rich proteins.  
4. Stratum lucidum 
It is superficial to the stratum granulosum, is the pale, wavy, looking layer. This layer 
contains refractile droplets of eleidin. 
5. Stratum corneum 
This is the most superficial layer, the outer surface of which is exposed to the 
atmosphere. It consists of many layers of non-nucleated, flattened and cornified cells. 
6. Basal lamina (Basement membrane) 
The basement membrane acts as an anchor for the epidermis but allows movement of 
cells and nutrients between the dermis and epidermis. 
Dermis 
The dermis that is bounded distally by its junction with the epidermis and proximally by 
the subcutaneous fat. The basis of the dermis is a supporting matrix (or) ground substance in 
which polysaccharides; the matrix contains two kinds of proteins. They are 
Collagen     - Which has great tensile strength 
Elastin        - Which has considerable elasticity 
Hair follicles, various types of sebaceous and sweat glands, plain muscle fibres, and 
sensory end organs like pacinian and adipose tissue are seen in the microscopic section of the 
dermis. 
The dermis contains few cells, which are fibro blasts, mast cells, histocytes (or) 
macrophages, lymphocytes (or) other leucocytes and melanocytes. In the deeper layer of dermis, 
then in arterio-venous anastomosis surrounded by sphincter, the group of smooth muscles under 
autonomic control 
 Sweat glands 
             These are found in all areas of the skin. The sweat glands originate as down growths 
from the dermis. THIS   consists of a single unbranched tube that terminates in the form of a coil 
in the mid-corium. The coil is the secretory segment and is lined by a single layer of epithelial 
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cells. The duct runs straight upwards from it to the epidermis, which it transverses in a corkscrew 
manner to open on the surface at the pore. The latter is converted by a loose meshwork of horn 
cells. 
Sebaceous glands: 
             They are situated in the upper half of the corium. The sebaceous glands are derived from 
the epithelial cells of the hair follicles and are present everywhere in the skin except on the palms 
and soles. 
            They are multilobulated and covered by a connective tissue capsule within, which is a 
layer of small epithelial cells. As these cells mature towards the centre of the lobules they 
enlarge, their cytoplasm becoming arranged in a delicate network surrounding globular of fat 
(sebum). Towards the duct the whole cell disintegrates, lobulating its fat, the glands therefore 
being classified as a Nolocrine glands. 
Apocrine glands: 
             They occur in the axillae, areola and nipples of breasts, umbilicus, around the anus and 
the genitalia. The myo-epithelial cells are highly developed and more abundant in these glands. 
They are specialized sweat glands, and their secretion is odoriferous with a secondary sexual 
significance. 
 Hair 
              Hair is found on almost every part of the body surface except on the palms and the 
soles, the dorsal surface of the terminal phalanges, the inner surface of the labia, inner surface of 
the prepeuce and the glans penis. Hair growth and development is under endocrine control.         
               Hair is made of hard keratin and is analogous to nail. The hair matrix, a layer of 
specified epidermal cells, capping the papilla, forms it the two structures making up the hair 
bulb. Melanocytes are present in the matrix and form the pigment of hair. The portion of the hair 
below the surface of the scalp is known as the hair root. Above the surface of the scalp, the hair 
is composed of the medulla, cortex and cuticle. 
                The medulla consists of seven rows of soft keratin, but it is discontinuous (or) even 
absent in most human hairs. The cortex is the main structural component and is made up of 
tightly packed fusiform keratinised cells. 
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Nails: 
              These are semi-transparent, plates - like horny structures, covering the dorsal surfaces of 
the distal phalanges of the fingers and toes. The nail is composed of many layers of flattened 
keratinized cells fused into a homogenous mass. 
The anterior border encroaches upon the nail plate as a flattened keratinous, the cuticle 
and forms a protective barrier against irritants and infection. 
Blood Vessels: 
              The blood supply of the skin originates from a large number of arterioles forming 
anastamosis in the deepest part of the cortex. From here single vessels run upwards and form a 
second network in the upper cortex. Finally terminal arterioles ascend into the papillae ending in 
capillary loops; which drain into connecting venules. The blood is returned to the large veins in 
the subcutaneous tissue. 
Lymphatics: 
               The skin contains a rich network of lymphatics, which drain into a few larger vessels in 
the hypodermis. 
 Nerve Supply: 
              The nerve supply of the skin consists of a motor sympathetic portion derived from the 
sympathetic ganglia and sensory spinal portion arising from the dorsal root ganglia. The 
sympathetic fibres innervate the blood vessel, erector pilorum muscles and apocrine duct, where 
the fibres are adrenergic and cause contraction. 
PHYSIOLOGY 
1. Protective Function  
               Skin protects the penetration of harmful substances and bacterial invasions. The 
epidermis and subcutaneous fat play roles in the protective functions. Another is to protect 
against sunlight by synthesis of melanin pigment. 
2. Immunological Function 
   The skin is the front line of the defenses of the body. In essence the defense involves, 
the protection of antibody - complex, multi hair proteins that bind with the offensive antigens. 
Langerhan cells probably play a crucial role in the contact sensitization, immuno surveillance 
against viral infections and neoplasms. 
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3. Sensory Functions  
               The skin is richly supplied with nerves and various types of specialized sensory end 
organs, which provide information regarding environmental changes, so that the body can then 
adjust its activities accordingly. In some animals, the hair at certain situations have specialized 
sensory receptors located at the bases of the hair follicles that serve to enhance sensory 
appreciation. 
4. Secretions and Excretion 
                The skin possesses various types of glands, which pour secretions on the surface. The 
more important glands are sweat and sebaceous glands. The eccrine glands which are scattered 
all over the body surface secrete a thin, transparent, watery fluid, known as true sweat; while the 
apocrine glands secrete a thicker, rather milky and odoriferous solution. 
                Sweat in its composition consists of 1.2% solids and 98.8% water. The important 
substances excreted in it are sodium chloride, sodium phosphate, sodium bicarbonate, keratin 
and a small amount of urea. The skin can also excrete certain drugs administered to the 
individual, for example mercury, arsenic, iodine etc 
                The sebaceous glands of the skin secrete sebum, which is composed of fatty acids, 
cholesterol, alcohols etc. Fatty acids have a mild fungistatic activity. The sebum acts as a 
lubricant for the drying effects of the atmosphere. 
5. Gaseous exchange through Skin 
               A small amount of gaseous exchange occurs through the skin. In man the amount of 
Co2 exchanged through the skin is negligible compared to the amount exhaled from the lungs. 
6.Storage Function of Skin  
               Blood is stored in the rich sub papillary plexus of the dermis, about one litre. The skin 
is also a good storehouse of ergosterol that is irradiated, by the ultra violet light of the sun and 
converted into vitamin D.The junction between dermis and hypodermis has a considerable 
capacity for storing fat and permanent store of subcutaneous adipose tissue. Certain substances 
like glucose and chloride also acts as a reservoir for topically applied corticosteroids (or) other 
hormones that absorbed slowly for many days from the skin surface. 
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7. Endocrine Function 
                 Hair follicles and sebaceous glands are the targets for androgenic steroids secreted by 
the gonads and the adrenal cortex and melanocytes and directly influenced by polypeptide 
hormones of the pituitary. 
8. Body Heat Regulation 
                The skin plays the most important role in the regulation of heat loss. It loses heat to the 
external environment in three ways: by conduction, by radiation and by evaporation. Heat loss by 
the first two mechanisms takes place when the environmental temperature is lower than that of 
the skin. Heat loss by evaporation mainly means the amount of heat spent by the body to 
evaporate the sweat from the surface of the skin. About 90% of the total heat the skin regulates 
loss of the body. 
               The heat loss through the skin is regulated by various physiological mechanisms that 
include the reaction of the cutaneous vessels. The reaction of the smooth muscle fibers of the 
skin and Perspirations. 
9. Absorption  
               The skin can absorb substances dissolved in fatty solvents like vitamins and hormones. 
Inflammation greatly increases the skin permeability substances that are completely insoluble in 
water and lipids do not penetrate. 
10. Synthesis of vitamin D 
                Vitamin D is synthesised in the skin as a result of exposure to ultra violet 'B' (UVB) 
radiation and, since it is carried in the blood attached to a binding protein to exercise a specific 
effect at a different site. Vitamin D5 is essential for skeletal development, and it contains 
antirachitic properties. Vitamin D3 is formed principally in the stratum spinosum and the stratum 
basale, from the precursor 7 - dehydrocholesterol by way of a provitamin D3 (2, 5). 
FUNGI 
The importance of Fungi 
 Fungi were long regarded as primitive or degenerate members of the plant kingdom, but 
their independence as group is now universally recognized. Since they are incapable of 
photosynthesizing their own organic food requirements from C02 and water, they must exist as 
saprophytes or parasites.    
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 Between 50,000 to 1, 00,000 species are known, some are aquatic, some are marine but a 
majority is terrestrial. Most fungi are saprophytic and play and importance role in nature by 
returning to the soil nutrients originally by higher plants. Their ability to transform sugar into 
alcohol and Carbon-di-oxide, along utilized in brewing and baking. Their capacity for producing 
antibiotics, for example Penicillin has long been recognized and exploited. 
 In agriculture fungal pathogens are responsible for losses amounting to perhaps 10% of 
the world's crops. Fungi can also harm man more directly by producing mycotoxins, by acting as 
allergens and by direct tissue invasion. 
Fungal biology 
Fungi are Eucaryotic microorganisms 
  Sub division: Ascomycotina 
  Genus:  Arthoderma 
  Family: Gymnoscaceae 
              Fungi differ form the higher plants in structure, nutrition and reproduction. Fungi and 
bacteria are like in lacking chlorophyll and therefore being unable to photosynthesize, but differ 
from each other in many ways. In size, in cytoplasmic and morphologic complexity fungi greatly 
exceed bacteria. 
Fungi 
 Fungal cell wall is rigid usually composed of chitin, glucan and mannoproteins. The 
cytoplasmic membrane of fungi contains sterols principally ergosterol, which are the target sites 
of action for the major classes of antifungal drugs. 
Fungi may be unicellular for example; the yeast, or the cellular units may be connected 
together to form long filaments of hyphae as in the common moulds. In the terms of intracellular 
organization yeast and moulds are essentially similar and certain conditions some yeast may 
become filamentous and some moulds may grow multiply as yeast. This ability to change their 
form is known as dimorphism and is highly characteristic of some pathogenic fungi, e.g. 
Blastomycesdermatitidis, Histoplasma Capsulatum. 
The hyphae are usually divided into cells by cross walls or septa, whent the interwoven 
mass of hyphae remaining loosely arranged, it is known as mycelium. 
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This undifferentiated mycelium forms the basic vegetative body or thallusand is often 
inconspicuous. It is the developement of various structures, from or on the hyphae for purposes 
of propagation perennation that give the characteristic features associated with fungi grown on 
culture media. 
The distinctive surface colours and textures of any moulds are due to the formation in 
great numbers of minute spores, which are capable of being spread easily and thus initiating new 
growths. Spores differ from species to species. 
 Reproduction 
 Fungus reproduces its generation by 2 ways. 
Asexual reproduction 
Sexual reproduction 
Normally the rapid vegetative growth, which follows successful colonization, gives way 
to the production of a sexual reproduction. Ultimately the loss of nutrient source or the onset of 
other adverse conditions is accompained by changes appropriate to survival and a low level of 
metabolic activity leads to sexual reproduction. 
            1) Asexual reproduction 
Vegetative spores (chlamydospores/Arthrospore) 
↓ 
Sporophores (spore bearing hyphae) 
    ↓ Mitotic nuclear division 
Asexual spores 
Asexual spores vary in size, shape colour and complexity. A fungus may produce more 
than one type of asexual spore. 
Types: 
1. Microspore:  Microconidium 
2. Macrospore: Macroconidium 
3. Sporangiospore: Spores borne endogenously 
4. Conidiospore: Spores borne exogenously or conidia 
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2) Sexual reproduction 
Sexual reproduction involves the fusion of two nucluei and subsequent meiosis 
reduction division. Fungi are often haploid and meiosis takes place following fusion, except in 
certain yeast the diploid state is relatively short lived. This stage of life cycle is known as the 
Perfect state or telomorph. 
According to different methods of asexual reproduction the fungi are classified into four 
classes. 
Zygomycets:  eg. Mucour sp. Rhizopus sp. 
Ascomycets:  eg. Arthroderme sp. 
Basidiomycets:  eg. Mushroom, Toadstools 
Fungi imperfecti:  eg. Candida sp., Microsporum sp., 
  (Deuteromycets) Trichophyton sp.,HistoplasmaCapsulatum.            
Classification of disease caused by fungi (Mycoses): 
1. Cutaneous/superficial mycoses: Infections that involve only the skin and its 
appendages, eg. Dermatophytosis. 
2. Systemic mycoses: Fungal infections; that spread via lymphohematogenous 
dissemination to involve one or more organs, such as lungs, skin, liver, spleen and 
CNS. eg. Candidiasis. 
3. Endemic mycoses: Prone to cause disease due to altered host defence. 
Definition 
             Dermatophytosis represents the superficial infection of Keratinized tissue caused by 
dermatophytes. (Dermatophytes - are related fungi capable of causing skin changes of the type 
known as ringworm). 
History 
              The study of dermatophytosis has been aided by the superficial nature of its clinical 
manifestations. These infections were described in the earliest historic accounts.                 
"Tinea" a name that remains today, literally refers to an insect larva (clothes moth) that was 
thought by the Romans to be the cause of the infection. 
    In 1800s - The organism responsible for favus cultured. 
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                1910 - Sabouraud (Father of modern medical mycology) - classification of 
dermatophytes and observation are made (clinical and therapeutic) 
EPIDEMIOLOGY  
                     Agent Factor: 
         A. Thedermatophytes represent 39 closely related species in 3 imperfect 
genera. 
1. Microsporum 
2. Trichophyton 
3. Epidermophyton 
B. Depending upon their natural habits dermatophytes may be classified as 
               1. Geophilic organisms 
Adopted for soil habitation sporadically infest human and less pathogenic for 
humans. Example: Microsporum cookie, N. fulvum, Tinea ajellos. 
               2. Zoophilic organisms 
Primarily infect higher animals but can be transmitted to humans sporadically, eg.  
a) Microsporumcanis - Dog, cattle, cat sheep, pigs, rodents, monkeys. 
b) Microsporumdistortum - Dog, cat, horse, monkey 
Causes severe inflammation.But more readily curable. 
Domestic animal and pets are increasing source of this infection 
              3. Anthorpophilic organisms: 
Often epidemic in nature, have adapted to infect humans. 
The cause mild but chronic lesion and transmission by direct contactor through 
fomities. 
Host differences play a role in the Epidemiology of anthropophilic infections. 
C. Endemic areas (Geographical Location) 
Dermatophytosis occurs throughout the world but certain types of disease and some 
species of fungi show geographically restricted distribution. Eg. Microsporummannum - 
Cuba (Endemic region) T. Concentricum - India, Pacific Islands, Ceylon, Central and South 
America. 
      Host Factors 
Host differences play a role in the epidemiology of anthropophilic infections. 
Intercurrent diseases, altered host defence system are important host factors. 
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  Other Factors 
    1. Age: Anthropophilictineacapitis occurs more in children. 
                 2. Sex and Race :  
I. Black male children appeared to be particularly susceptible. 
II. Females - Tricophyton Tineacapitis when occurring in adults is common for 
the Female. 
III. Males - Tineacruris more common in males.The causes for the sex differences 
in infection may be explained partially by females are less frequently exposure to 
an environment conductive to the spread of the organism, (eg. athletic 
organizations, military service, and hotels) when these factors are equalized; the 
incidence of tinea in women approaches that in men. 
                       The location of the dermatophytosis is partially dependent on climatic condition of 
the area and the customs of the resident population, eg. Tineapedis -more common in areas 
where all wearing shoes. In locations where the inhibitants were sandals or go bare foot the 
infection is markedly less common. 
Common predisposing factors or conditions 
 Overcrowding, poor personal hygiene, low socio economic condition. 
            Interruption in anatomical barriers, (burns and endotracheal tubes) or indwelling foreign 
bodies (catheter, prosthetic heart valves/joints) granulocytic dysfunction, secondary to 
hematological malignancies (leukaemia) or cytotoxic chemotherapy, depressed cell mediated 
immunity associated with organ transplanation, AIDS or immunosuppressive therapy, 
(corticosteriods therapy) and diabetic ketoacidosis, intravenous drug abuses. 
              Fungi are facultative pathogens, (only in the presence of certain adjuvant factors like 
trauma, maceration, warmth, lack of fresh air and sunlight to a part, previous infection, 
sensitation and debility). 
               Importance of the body's basic resistance (condition of the soil) must be appreciated in 
comparison with the causative organism and fungi, or which undo stress has been laid in the part. 
Pathogenesis 
Presence of a suitable environment on host skin is of critical importance in the 
development of clinical dermatophytosis. Trauma in addition, increased hydration on the skin 
with maceration is important. 
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Occlusion with a nonporous material increases the temperature and hydration of the skin 
and interferes with the barrier function of the stratum corneum, (eg. wearing non-porous shoes 
definitely contributes to the developement of Tineapedis). In tropical climates non-acclimatized 
subjects often develop lesions of Tineacorporis, in part because of occlusive clothings. 
Stage   
If the host is inoculated under suitable conditions, the first phase of dermatophyte 
invasion involves the adherence of infectious spores to keratinocytes on the stratum corneum. In 
vitro this process is completed after 2 hours of contact. 
There follow several stages through which the infection progresses. 
1. A period of incubation 
2. Enlargement followed by refractory period 
3. Stage of involution. 
A. During incubation period; a dermatophyte grows in the stratum corneum, sometimes 
with minimal clinical signs of infection. A carrier state has been postulated when the presence of 
a dermatophyte is detected on the normal skin by Potassium Hydroxide examination or culture. 
During the early (i.e. incubation) phase of dermatophyte infections, organisms are present but are 
clinically silent. Only a limited number of these patients will develop clinical disease during 
follow-up-period. These individuals presumable represent true carriers. 
Once infection is established in the Stratum corneum, two factors are important in 
determining the size and duration of the lesion. 
There are, 
1. Rate of growth of the organism. 
2. Epidermal turnover rate. 
The fungal growth rate must equal or exceed the epidermal turnover rate or the organism 
will be shed quickly. 
The inflammatory response at the rim of the lesion stimulates an epidermal turn over in 
an effort to shed the organisms. 
Lag periods between the initiation of the infection, lost inflammatory response and the 
increased epidermal turn over are known as refractory periods. 
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Following this, only the organisms at the inflammatory rim are being shed, while those 
just ahead maintain the infection. 
The centre of the lesion has relatively few organisms in contrast to the 'battle ground' of 
the peripheral rim. 
Stage of involution  
The affinity of dermatophytes for keratin is the sine quanon of their existence. Different 
species of dematophyte are attracted to different types of keratin. 
e.g. T Rubrum - Seldom attacks hair but frequently involves nails and glabrous skin. 
 E. Floccosum - rarely involves nails and never intacts hair. 
Keratinases and other proteolytic enzymes are produced by dermatophytes. There is a 
significant correlation between inflammation and enzyme production. 
The host immunologic response and also enzyme or toxins produced by the organism 
account for the clinical findings in dermatophytosis. Other factors are probably involved, but 
they have not been elucidated yet. 
Histopathology 
 The clinical appearance of ringworm infection is the result of combination of direct 
damage to the kerantinized tissues by the fungus and the inflammation host response. 
 Ringworm infection may mimic other skin disease. Trichophytonrubrum in particular 
shows hyperkeratosis, patchy parakeratosis, hyper or hypogranulosis, spongiosis, monouclear 
invasion, and mild or moderate acanthosis accompanying dermal infiltrate of lymphocytes and 
histiocytes is largely perivascular. 
 The picture may be more inflammatory with superficial crusting and acute inflammatory 
changes in the epidermis and become vesicular to the extent of mimicking acute contact 
dermatitis. 
 Another picture is granuloma faciable type of reaction in which the epidermis and upper 
dermis are normal but the mid dermis has an infiltration proximal to dilated blood vessels. 
 Pustular reaction includes subcorneal changes and follicular lesion. The folliculitis and 
perifolliculitis are due to fungal reminants in the follicles. 
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 Inflammatory changes ranges from spongiosis of the outer roof sheath to deep 
perifollicular granulomatous inflammation showing necrosis induced by fragments of hair 
exuded from disrupted follicles. 
 Most of the inflammatory changes are thought to be mediated by immune reaction. 
T.rubrum is a fairly potent direct activatory of complement by the alternative pathway and 
possibly other endogenous pathways. 
Annular lesions: 
 In a classical annular ringworm lesion, the growing edge is marked by inflammatory 
changes in the skin. In the central area of the inflammation subsides following elimination of the 
fungus mycelium. Outward growth continues in preference to any attempt at centripetal 
recolonization. 
The epidermal turnover rate is normal within the ring, but 4 times more in the inflamed 
zone, central clearance is often partial and in Tineaimbricata, successive waves of fungal growth 
occur in skin previously cleared, but progress is again centrifugal. 
Immunology of Ring Worm 
Dermatophytes are chemotactic and they can activate the alternative pathway of 
complement activation. The antigen diffuses from the stratum corneum to stimulate sensitized 
lymphocytes. Inflammatory mediators and lymphokines are produced by their cells and probably 
act on the host cells rather than on the dermatophyte. Because of this response, the epidermal 
barrier is abrogated. 
The production of cytokines by keratinocytes such as IL-I have not been investigated in 
the mobilization of neutrophil defense. Neutrophils and monocytes can kill dermatophyte 
conidia. This actively depends on both intra and extra cellular mechanisms and the generation of 
respiratory burst is an important stage in this process. 
The generation of antibodies to dermatophytes plays a major role in defense, patients 
with widespread infection such as Tineaimbricata may have high antibody titter, and low titter of 
SIR (Serum Inhibitory factor), the presence of elevated levels of IgE in particular is associated 
with chronicity, and so, the cell mediated immune response typically leads to inhibition, no 
complete destruction of the dermatophyte. 
In man the appearance of inflammation in ringworm correlates with type IV with the 
development of delayed type skin reactivity to Trichophtin. Chronic infections are associated 
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with poor T.lymphocyte mediated response to specific fungal antigen suggesting that depression 
of responses is responsible for the Poor clinical response. The developing of cellular immunity 
via sensitized T-Lymphocytes is a key factor in immunological defense. After the development 0f 
cell mediated immunity the infected area becomes less inflammatory and eventually 
spontaneously involves. If a second infection with the same organism is produced in the same 
subject at a later time, the site becomes inflammatory very early and resolves relatively quickly. 
There is an association between the presence of atopy and chronic dematophytosis with 
persistent disease, having atopy (usually asthma or hayfever) as well as immediate type of 
hypersensitivity and raised IgE level. Patient with this atopic chronic - dermatophytosis 
syndrome are capable of delayed hypersensitivity skin test reaction, but these reaction are 
inhibited by the more sensitive preceeding type I response. 
Modulation by T.-Lymphocyte either locally or systemically may be responsible or 
include activiation of histamine responsive suppressor cells. Other studies have demonstrated the 
antagonistic effects of histamine on the cell-mediated immune response. This finding has 
important therapeutic relevances as the use of an H2 histamine blocker (cimetidine) may prevent 
this antagonism and so enhance the patients own delayed hypersensitivity reaction. 
Dermatophyte antigen affects expression of T-Lymphocyte responses. Chronic infection 
due to T.rubrum produce dry type infection associated with poor lymphocyte transformation 
responses compared to other dermatophytes. 
Non-Immunological Defence against Ring Worm 
             Apart from immune mechanisms, there are various host factors, which are important in 
determining, whether or not particular individual infected with a fungus or if infected whether 
that infection clears spontaneously. 
Epidermal Integrity 
             Normal intact dry epidermis is resistant to dermatophyte infection. Mild trauma to scalp, 
more severe trauma to the feet or maceration by occlusion have always been required to achieve 
infection. 
Epidermal turnover 
             When the invading dermatophyte to retain a bridgehead on the host must invades 
through stratum corneum or hair or nail at a rate alteast equal to that at which these tissues grow 
outwards.Whether the very fast growing epidermis of the psoriatic plaque in the psoriatic subject 
34 
 
is more resistant to fungal infection is not reliably known. Successful experimental inoculation of 
dermatophytes into psoriatic plaque has been reported but the occlusion used had some inhibiting 
effect on epidermal turnover. 
Saturated fatty acids    
              Some saturated fatty acids with 7,9,11 & 13 carbon chains abstracted from adult hair 
and dervied from sebum were inhibitory to fungi. Due to their presence on their skin in post 
pubertal children may account for the spontaneous resolution of tineacapitis after this age and the 
rarity of infections in adults. 
Age, Sex, Genetic and Racial Factors 
                There may be racial difference of susceptibility but they are not clear-cut. Negroid skin 
seems to be relatively less susceptible to fungal infection that the Caucasoid. In Tinea imbricata a 
genetic susceptibility factor inherited as an autosomal recessive has been suggested. 
Endocrine and Metabolic Factors 
               No reliable evidence that the diabetic patient is a especially susceptible to dermatophyte 
infection. In malnutrition and in Cushing syndrome the apparently diminished resistance to 
infection is attributable to depressed cellular immunity. 
Temperature          
               Exception of T-verrucosum, all dermatophytes grow poorly at 37°C. This factor alone 
may be responsible for the lack of deep invasion by this group of organism. 
Completing organisms and co-pathogens 
              Penicillin like antibiotics shown by certain dermatophyte species might be taken as 
evidence for an antagonistic relationship between the fungi and the normal skin. 
Staphaylococcus act, as a co-pathogen increasing the degree of inflammation in fungal infection. 
CLINICAL FORMS OF RINGWORM INFECTION: 
Classification of Tinea 
Clinical forms of ringworm infections are classified traditionally according to the site of 
the body infected. 
           They are: 
             1. Tineacapitis  -          Ringworm of the scalp (or) Tineatonsurans. 
             2. Tineabarbae  -  Ringworm of the beard 
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             3. Tineacorporis  -   Ringworm of the body (or) Tineacircinata 
             4. Tineamanuum  - Ringworm of the hand. 
             5. Tineaunguium  - Ringworm of the nail 
             6. Tineacruris              -          Ringworm of the groin, dhobie's itch, Jocket Itch. 
             7. Tineapedis     - Rignworm of the foot, athlete's foot. 
 
Clinical forms of 
Ringworm infection Name of the organism 
1. Tinea capitis Microsporumcanis, M.audouniiTrichophytontonsurans M. verrucosum. 
2. Tinea barbae T. mentagrophytes, T. Verrucosum. M.canis, T.rubrum 
 3. Tinea corporis T.rubrum, T.mentagrophytes, M.canis. 
4. Tinea cruris Epidermophytonfloccosum, T.rubrumT.mentagrophytes. 
5. Tinea manuum and      
    Tineapedis 
T.rubrum, T.mentagrophytes, E.floccosum. 
6. Tinea unguium T.rubrum, T.mentagrophytes. 
 
Tinea/Ring worm is a group name for a highly contagious, segmented mycelial fungus; 
there are three distinct genera in this group. 
1. Epidermophyton: 
  Affects only human skin, there is only one important species E.floccosum. 
2. Trichophyton: 
             More virulent than others. It affects the hair, the glabrous skin, as well as the nails; it 
includes both the human and animal species. 
Important species are T. Rubrum, T. Mentagrophytes, T. Violaceum, T. Verrucosum and 
T. Schoenleint. 
3. Microsporum 
It affects mainly the hair and less commonly, the glabrous skin. The important species 
are: M. audounii (Human variety), M. canis, M.lanosum (Animal varieties)  
Causes the most fungal infections of skin 
Trichophytonrubrum. 
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CLINICAL FEATURES 
TINEA CORPORIS (TINEA CIRCINATA) 
Definition 
            All dermatophyte infection of glabrous skin with exclusion of certain specific location i.e. 
palms, soles and groin. 
Epidemiology 
             Transmission is by direct contact with other infected individuals or by infected animals, 
clothing and furniture.Under appropriate environmental condition (warmth, humidity), a 
reservoir of infection on the feet or elsewhere may be the source of Tineacorporis.In children the 
infection is due to zoophilic organism transmitted by contact with pets (especially cats and dogs). 
Clinical Manifestation 
1. Typical annular lesion with an active, erythematous and sometimes vesicular border 
with central clearing. 
2. In T.rubrum and in T.imbricata infection the centre shown concentric rings. 
3. In T.rubrum confluent plaques of infection may occur. Polycyclic lesions are also seen 
frequently. 
4. When the infection is due to a zoophilic organism the lesions are commonly seen on 
exposed skin (head, neck, face and arms). 
5. When the infection due to anthropophilic organism, occurs in occluded areas or in 
areas of trauma (perifolliculitis of the legs in women may be associated with leg 
shaving) 
DIFFERENTIAL DIAGNOSIS 
1. Annular lesions of Psoriasis: 
Silvery scales, candle grease sign. Typical lesions of elbow, knees, scalp and nails. 
2. Nummular Eczema 
            No active inflammatory border, Bilaterally symmetrical patches, Usually on limbs in 
winter. 
COMPLICATIONS 
            Extension of the infection down the hair follicles. (More difficult to cure) Pyoderma  
Dermatophytid reaction 
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PROGNOSIS 
             Treatment should be continued for 1-2 week after clinical curing. 
Usually responds promptly to conservative topical therapy within 4 weeks or to antifungal drugs 
by mouth. 
TINEA CRURIS 
             Tineacruris is a dermatophytosis involving the groin area and include infections of the 
genitalia, pubic area, perineal and perianal skin. 
Epidemiology 
              Direct contact, trauma are the mode of transmission. 
              It is almost exclusively a male dermatophytosis depend on several factors. Indirect 
transmission occur through contact with non living objects that carry infected scales like bed 
lines, towels, articles of clothing, and even bed pans of urinals. 
Clinical Manifestation 
A. Well-marginated raised border that may be composed of multiple erythematous papulo 
vesicles. 
B. Pruritis, pain may be present if the involved area is macerated or secondarily infected. 
C. Often thigh adjacent to the scrotum is the tissue site involved. 
D. Chronic scratching may cause lichenification. 
E. Weeping, maceration and areas of pustulation may exist. 
F. Irritant contact dermatitis may be present if sensitization of irritating topical products has 
been used in treatment. 
Differential Diagnosis 
1. Candidiasis - Bright red and marked by satellite papules and pustules out side the main 
border of the lesion. 
2. Seborrhoeic dermatitis - Often involves with face, sternum and axillae. 
3. Intertrigo - More red, less scaly and present in obese individuals in moist body folding. 
4. Psoriasis - Distinct plaques on other sites of the body. 
Prognosis 
              Responds promptly to topical or systemic treatment. It may leave behind Post - 
Inflammatory hyperpigmentation. 
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TINEA CAPITIS 
More frequent in boys than girls. Ringworm of the scalp in which the essential feature in 
invasion of hair shafts by a dermatophyte fungus. 
There are three varieties. 
1. Scaly variety 
The commonest, caused by microsporum. A circular patch or patches of partial alopecia 
with thin greyish scales. Broken lustreless stubs of hair 
2. Kerion variety 
Caused by Trichophyton. In the beginning small boil like lesion with little oozing and no 
pus.Later red, painless, boggy swellings are produced, and have no pus. Lesions are irregularly 
distributed on the scalp along the area of partial alopecia. 
3. Black-Dot variety 
Caused by Trichophyton, Appearance of black dots and it can always be detected at the 
periphery of the lesion. Alopecia may look almost complete 
Carrier state in tineacapitis 
A carrier is a person who does not have clinical signs of tineacapitis but has a positive 
culture from the scalp. In families in whom tineacapitis is identified, the carrier rate in is around 
30%. The presence of these carriers will reduce the cure rate for tineacapitis if they are not 
treated concomitantly. 
Differential Diagnosis 
1. Seborrhoeic dermatitis: 
              Uncommon in children, 2-8 years of age. In this age range seborrhoeic dermatitis is rare. 
2. Alopecia Areata: 
Well defined patches of Complete alopecia. Absence of dull, broken hair and greyish 
scales, presence of "exclamation mark" hair. 
3. Impetigo: 
Culture positive for staphylococcus aureus. 
Prognosis: 
Tinea capitits should be treated whenever detected. Rarely permanent alopecia may result 
in kerionvarity. 
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TINEA PEDIS AND TINEA MANUUM 
Tineapedis is a dermatophyte infection of the feet;  
Tineamanuum is a dermatophyte infection of palms, and interdigital areas of the hand. 
Epidemiology 
Infection is common during the summer months and in tropical or sub tropical climates. 
Incidence of Tineapedis is definitely higher in any population that wears occlusive shoes. 
Infection rate is increased using commonal bath or pools. It is an exogenously transmitted 
infection in which cross infection among susceptible individuals readily occurs. 
The rate of infection is much higher in closed communities like athletic teams, military 
organization and boarding schools. 
Clinical Manifestations 
1. Tineapedis may present as one of 4 clinically accepted variants. Chronic infection is the most 
common and is characterised by fissuring, scaling, and maceration in the interdigital or sub 
digital areas. 
2. The lateral (ie. 4th to 5th or 3rd to 4th) toe webs are the most common sites of infection. From 
here infection may spread to the sole or instep of the foot, but it seldom involves the dorsum. 
3. Aggravating factor is warmth and humidity. 
4. Hyperhidrosis may be an underlying problem and should be treated along with the 
dermatophytosis. 
1st type; Interspace showed maceration, white hyperkeratosis or erosions with increasing 
patients symptomatoloty, an overgrowth of the bacterial flora including gram - negative was 
noted. It was found that the clinical picture of symptomatic "athlete's foot" results from the 
interaction of bacteria and dermatophyte. 
2nd type: Chronic papulosquamous pattern usually bilateral, characterised by minimal 
inflammation, diffuse scaling over the soles. In addition to the feet the hands may be involved as 
well as multiple toenails. A common presentation is, "One hand, two feet presentation observed 
with T.rubrum infection". 
3rd Type: Vesiculo bullous type caused by T.mentagrophytes. 
4th type: Acute ulcerative variant associated with maceration, weeping of ulceration, 
obvious white hyperkeratosis and a pungent odour is characteristically present. This infection is 
often complicated by a secondary bacterial overgrowth (especially gram negative bacteria) 
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Differential Diagnosis 
Psoriasis - Repeated fungal culture give negative result. 
Contact detmatitis - Often involves the dorsal surface of feet. 
TINEA BARBAE OR TINEA SYCOSIS (BARBER'S ITCH) 
It is a fungal infection limited to the coarse hair - bearing beard and moustaches area of 
men. 
Epidemiology 
Tinea barbae is by definition seen only in males. Contaminated barber’s razors or clippers 
transmitted it from person to person. The infection is by exposure to animals like cattle and dogs. 
Clinical Manifestations 
They are 3 clinical types 
1. Inflammatory or kerion like 
2. Superficial or sycosiform type 
3. Circinate spreading type 
1. Inflammatory type 
Unilateral lesions, common areas of involvement are chin, neck, maxillary and 
submaxillary areas. Upperlip is usually spared. 
The lesions are nodular and boggy associated with weeping of seroprulent material with 
crusting. Perifollicularpustulation is observed. 
2. Superficial type 
Typically resembles a bacterial folliculitis. Diffuse erythema associated with 
perifollicular papules and pustules 
3. Circinatetinea 
There is an actively spreading vesiculopustular border with central scaling; there may be 
a relative sparing of hair in this variant. Atypical tineabarbae may also see especially if the 
course of the disease is altered by corticosteriod or other therapy. 
Differential Diagnosis 
Sycosisbarbae: Chronic congestion of the skin of the beared region with superficial 
follicular pustules. 
Prognosis 
Prognosis is good as regards complete cure. Scarring and alopecia however are the end 
results of the inflammatory type. 
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TINEA UNGUIUM 
Synonyms: Onychomycosis 
  Tineaunguium is clinically defined as a dermatophyte of the nail plate.  
Epidemiology: 
Approximately 30% of patients with dermatophyte infections on other parts of their body 
also have tineaunguium. Fungal nail infections are always exclusively an adult disease, because 
the faster nail growth in children appears to make infection more difficult. Infection is higher in 
men than women though the number of cases affecting the toenails is increased in women due to 
their narrow toed shoes allow increasing crowding off and greater burden of wet work performed 
by females. Fungal nail infections are more chronic and recalcitrant to therapy and these 
infections provide an endogenous source for reinfection of the feet. 
Clinical Manifestations 
1. Distal subungualonychomycosis (DSO) 
Whitish or yellowish discolouration at the free edge of the nail or near the nailfold. As 
the infection progresses subungual hyperkeratosis may lead to an operation of nail plate and nail 
bed. Fungi invade the nail plate from the ventral surface and in time the entire nail may become 
friable and discoloured. Subungual debris also provides a site for opportunistic secondary 
infection. 
2. Proximal subungualonychomycosis (PSO) 
First clinical sign of the type is whitish-to-whitish brown areas on the proximal part of 
the nail plate. The area may gradually enlarge to affect the entire nail. 
3. White Superficial Onychomycosis (WSO) 
White colour on the surface of the toenails. The surface of the nail is usually rough and 
friable, as the "eroding fronds" of the organisms remain quite superficial. T.mentagrophyte 
produces WSO. 
Clinical manifestations: 
· The condition is very rarely bilateral and symmetrical. 
· Tinea affects first the free edges of the nail. 
· Opaque, brittle and deformed nail or nails and hyperkeratotic debris under free edges 
characterize tineaunguium. 
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· There is no pain and itching. 
· The diagnosis is confirmed by the demonstration of fungus in the hyperkeratotic debris 
and nail cuttings.  
DIFFERENTIAL DIAGNOSIS: 
Psoriasis:   
Moniliasis 
Paronychia 
Leprosy :     
TINEA NIGRA 
A superficial dermatomycosis caused by Phaeoanellomyces (Exophiala) werneckii. This 
is a dematiaceous (pigment-producing) fungus. It causes an asymptomatic tan, brown, or black 
patch on the palms or soles. Demonstrating pigmented hyphae on a KOH examination of the 
lesion makes the diagnosis. Tineanigra has been confused with acrallentiginous melanoma. 
TINEA FAVOSA (OR) FAVUS 
It is a chronic mycotic infection of the scaly glabrous skin and or nails characterized by 
the formation of yellowish crusts within the hair follicles (scutula) and eventuating in a cicatrical 
alopecia. 
Epidemiology 
Favus is typically a chronic infection that begins early in life and commonly extends into 
adulthood. This is predominant in rural areas associated with poor hygiene and malnutrition. 
Relatively intimate and prolonged contact is probably required for transmission. Cleanliness with 
the removal of hairs or other sources of infection is an important factor on controlling the 
disease. 
Etiology: 
              Common dermatophytes producing  favus  is T.schoenleini. 
Clinical Feature 
             Scutula are found in most cases of favus. They gradually expand form a yellowish - red 
papule to form a yellowish, cup shaped structured that may become 1 cm or more in diameter. A 
single, lusterless, dry hair pierces the center of the scutulum, the colour (yellowish) is due to the 
invasion of the hair by multiple intrapilar hyphae. 
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If the scutulum is removed from its attachment to the epidermis, an oozing, erythematous 
base is noted. When hygienic conditions are lacking, a characteristics "Mousey" odour may be 
appreciated.  
In the classic presentation lesions appear in a patchy distribution on the scalp and 
coalesce of polycyclic in shape. The center of the infected area becomes extensively scarred and 
almost totally devoid of hair. Besides scalp, favus may involve glabrous skin and nails. In later 
stages a cicatrical alopecia may be present. 
Majocchi's granuloma is a follicular abscess produced when a dermatophyte infection 
penetrates the follicular wall into the surrounding dermis. Patients usually present with one or 
more tender boggy papules or plaques on the legs or, less commonly, arms. Pus may be seen drar 
from the hair follicle. Trichophytonrubrum or T. mentagrophytesare the species most co-isolated 
from these lesions. Treatment should consist of an oral antifungal agent. 
Tinea incognito 
This is the name given to extensive ringworm with atypical appearance due to the 
inappropriate use of topical crtiocosteroids. The corticosteroids suppress the protective 
inflammatory response of the skin to the ringworm fungus allowing it to spread and alternating 
its appearance.  
LABORATORY DIAGNOSIS OF THE SUPERFICIAL MYCOSIS 
Dermatophytosis 
Although, the diagnosis of superficial fungal infection can be strongly suspected on 
clinical grounds, it is usually prudent and sometimes essential to seek laboratory aid. Direct 
microscopic examination, culture of selective materials, and woods lamp examination should be 
made whenever possible. 
Collection Specimens. 
In dermatophyte infections, the active border of the lesion contains the viable organisms 
and is most likely to give positive results. It must be scraped with a sterile scalpel and any hair 
stubs should be plucked with sterile forceps. Once collected, specimen should be examined 
rapidly or placed in dry containers, such as clean dishes or paper envelopes; a folded piece of 
black paper is most appropriate. In Tinea unguium, the nail bed is raised at the distal end and the 
powdery debris is removed from under the nail with a slightly curved needle. 
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Skin Scrapping 
The specimen is cleaned in 10-20% potassium hydroxide. Microscopic examination is 
carried out using low-power and high-power lenses of direct microscopy. 
Scrapping of the skin are examined as for hair. Spores can be differentiated from artifacts 
because they are of uniform size, and hypae are differentiated from fibres by being branched. In 
onychomycosis, part of the nail is cleaned in 10% potassium hydroxide overnight to dissolve 
away the keratinous material and allow the fungal elements to be seen that penetrate through the 
epidermal scales. Round or barrel-shaped spores are also found.  
The material is first placed on a glass slide, and then 1 or 2 drops of 10-20% potassium 
hydroxide (KOH) are added. A fungal stain such as chlorazol black E may be added to the 
preparation to aid visualization of the fungal elements. The hyphae of dermatophytes will be sep-
tate and typically demonstrate branching. Mosaic hyphae actually represent thickened stratum 
corneum cell walls. True hyphae cross the cell walls of keratinocytes and do not conform to the 
contour of keratinocytes. 
Sabouraud's dextrose agar:  
A nonselective culture medium consisting of peptone, dextrose, agar, and distilled water. 
It allows the growth of bacteria as well as pathogenic and nonpathogenic yeast and molds. 
This may be required not only to confirm the diagnosis but also to identify the species of 
the causative fungus.  
Woods lamp examination 
A Wood's lamp is a light that uses long wave ultraviolet light. When an area of scalp that 
is infected with tinea (a type of ringworm fungus) is viewed under a Wood's light, the fungus 
glows (green yellow fluoresces). This test may be done to detect the presence of a fungal scalp or 
skin infection. 
A Wood's light is an ultraviolet light source that emits in the spectrum of 325-400 nm. 
This light was used extensively for the diagnosis of tineacapitis when Microsporumaudouiniiwas 
the major cause of this disorder. However, it is of limited usefulness today since most cases are 
now produced by Trichophytontonsurans, which is not fluorescent. 
The fluorescence is caused by pteridine. The fungi responsible for fluorescent are; Tinea 
capitis, T. Schoenleinii, M. Canis, M. Audouinii, M. Distortum, T. Ferrugineum 
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Histopathological examination 
Histopathological examination of a periodic acid Schiff stained section reveals hyphae 
and spores in the horny layer. Furthermore, the hypo-pigmented areas are characterized by a 
normal number of melanocytes whose dendrites are filled with small, sparsely 
melanizedmelanosomes. Also the number of melanosomes is reduced in many of the 
keratinocytes. This is explained by an abnormal maturation of melanosomes and partial block in 
their transfer to kerationocytes.  
Preventive Measures of Ring Worm Infections 
The skin should be kept dry, since skin favours the growth of fungi. 
1. The essential factor in prevention is personal hygiene. 
2. Dry the skin carefully after bathing or after perspiring heavily, and let it dry for 10-15 
minutes before dressing. 
3. Socks should be changed frequently. 
4. Loose-fitting underwear is advisable. 
5. Cutting of nail. 
6. Sandals Open toed chapels should be worn if possible.  
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PROPERTIES OF THE TRIAL DRUGS (INTERNAL) 
1. PARANGI CHAKKAI 
Botanical Name : Smilax Chinensis Linn. 
Family : Lilliaceae 
English Name : China root 
Part used : Root 
Organoleptic Characters: 
Taste : Inippu (Sweet) 
Potency : Seetham (Cold) 
Pirivu : Inippu (Sweet) 
General properties: 
      தாக  பலவாத  தா ந ட    பிளைவ 
      ேமக  க கிர தி   ல  – ேதக ட  
        ட பகர தேம  ெகா வமன  ேபா பற கி  
      ப ைடயிைன  சாி    பா                      (ேத. ) 
Actions: 
ª Alterative 
ª Antisyphlitic 
ª Aphrodisiac 
ª Depurative       
                        
2. SIVANAR VEMBU 
  Botanical Name         : Indigofera aspalathoides, vehl ex DC 
  Family                       : Papilionaceae 
  English name            : Indigo plant 
  Part used                  : Leaf,stem,root,flower 
 Organoleptic Characters:  
              Taste                    : Kaippu(Bitter) 
              Potency                : Veppam(Heat) 
              Privu                    : Kaarppu   
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General properties: 
                 ட  சிர   ைற     சமா ைத 
               க ட  பிணிக  கழ ேம-தி ட  
               உரனி ப  காய     டா  ேமைல 
               அரனி ப ெம  ம   தா .        (ேதர -ெவ பா) 
  Action     : 
ª Stimulant 
ª Demulcent    
 
3. CHANGANVER PATTAI 
Botanical Name   : Azima tetracantha,Lam. 
Family                 : Salvadoraceae. 
English Name      : Mistle toe berry thorn,Four Spined meneita. 
Part Used            : Leaf,Root,Milk    
Organoleptic Characters: 
             Taste        : Kaippu(Bitter) 
             Potency    : Veppam(Heat) 
             Privu        : Karppu 
General properties: 
             ச க ேவ   ப ைட சளியி மைல   ர ைத 
             அ கவா த க  ைப ஆடைத ைப -ப கேம 
             ெச    கிர திைய   தீகா  கி மிையயி  
             ைவய  தனிெலாழி   மா .                    (அ. ) 
Action :   
ª Diuretic 
ª Stimulant 
ª Astringent 
ª Tonic 
ª Antiperiodic 
ª Expectorant           
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4. VELLARUGU  
Botanical Name     : Enicostemma axillare.(Lam) Raynal 
Family                   : Gentianaceae                     
Part Used              : Poondu          
Organoleptic Characters: 
                    Taste            : Kaippu 
                    Potency        : Veppam 
                    Privu            : Karppu 
General Properties: 
               மெமா  வா   ட வாத  ைலயிைவ 
             ெச ம  வி  ேடா   சிைத  கா -வ  ைலயா      
             உ    கிர திெசாறி ெயா  ய சிர  ம   
             ெவ ள    த ைன வி   .              (அ. ) 
Actions: 
ª Stomachic 
ª Tonic 
ª Alterative 
ª Laxative 
ª Febrifuge 
 
5. KARUMBU 
Botanical Name         : Saccharum officinarum.Linn 
Family                       :  Gramineae (Poaceae )                                
English Name            : Sugarcane,Noble cane 
Part Used                  : Karuppancharu 
Organoleptic Characters: 
 Taste              : Inippu(Sweet) 
  Potency          : Seedham 
  Privu              : Inippu 
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General Properties: 
  அ    ம  தி  க பான மாக  
   ெபா   மட  வா திபி த  ேபா   -அ  த சி 
   நீ   மதிகப ைத நீ  மகி  சி   
  டா   ந  ச  க ைர.                (அ. ) 
Actions: 
ª Antiseptic 
ª Demulcent 
 
               PROPERTIES OF TRIAL DRUGS (EXTERNAL) 
                  6. NEERADI MUTHU 
Botanical Name       : Hydnocarpus laurifolia (Dennst) Sleumer. 
Family                     :  Flacourtiaceae                     
English name          : jangli almond.,marothi tree,Chaulmugra 
Part used                : Seed 
Organoleptic Characters: 
                  Taste            : Kaippu 
                  Potency        : Veppam 
                  Privu            : Karppu 
General Properties: 
         நீர   தி   நீ கா  கிர தி  ட  
         ேபாாி  வாத ேம ேபா  கா -கார     
         ெம  ழலா  ! பி த  மி மனல  உ டா   
          கிள  நைம சல   .                   (அ. ) 
Actions: 
ª Alterative 
ª Stimulant 
ª Detergent 
ª Parasiticide 
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7. KASA- KASA 
                  Botanical Name   : Papaver Somniferum, linn. 
                  Family                 :  Papaveraceae. 
                  English Name      : Opium poppy ,Poppy casules.  
                  Part Used            :  Seed 
Oraganoleptic Characters: 
                Taste      : Inippu 
                Potency  : Veppam 
                Privu      : Inippu  
General Properties: 
             கி மி நைம ச  கிராணியதி சார  
             சிரநீ  அநி திைரேபா  ெச பி -உ வழ   
             கா தி    டா   கசகசா வி  ண ைத  
             ேத  தவ    வி   மா  ேத .                 (அ. ) 
  Actions:  
ª Sedative  
                            8. KOPPARAI THENGAI 
        Botanical Name    : Cocos Nucifera. 
        Family                  :    Arecaceae 
        English Name       : Coconut palm,coconut tree. 
        Part Used             : Kaai 
Organoleptic Characters: 
         Taste      : Thuvarppu 
         Potency  : Thatppam 
         Privu      : Karppu 
General Properties: 
ேத காயி ென யதனா  றீயா  வ   ேபா  
பா காக   த  பட  ேத -நீ காத 
ப ல யி  ேனா   பட தா மைரசிர    
அ லற  ேபாெம  றறி.              (அ. ) 
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Actions: 
ª Refrigerant 
ª Aperient 
ª Nutrient 
ª Diuretic 
9. KATTU –CHIRAKAM 
         Botanical Name      : Vernonia anthelmintica willd. 
         Family                    :  Asteraceae               
         Engllish Name        : Purple fleebane 
         Part Used               : Seed 
 Organoleptic Characters: 
         Taste        : kaippu 
         Potency    : Veppam 
         Privu        : kaarppu 
General properties: 
     ைகக    மா   க யேம க ேபா   
     ெம  ளி   பி த  விைள ேமா-ெவ யகாிக 
     ேகா    பைண ைலயா  !  மவா த ெதாைல   
     கா  ந  சீரக ைத  கா .                        (அ. ) 
Actions:   
ª Anthelmintic 
ª Stomachic 
ª Tonic 
ª Diuretic 
ª Antiperiodic 
ª Alterative  
 
10. ARUNJ-CHIRAKAM 
    Botanical name      : Nigella sativa.Linn 
    Family                    : Ranunculaceae                      
    Englilsh Name        : Black Cumin;Small Fennel 
    Part Used                : Seeed 
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Organoleptic Characters: 
       Taste           : Kaippu 
       Potency       : Veppam 
       Privu           : Kaarppu 
General Properties: 
         க  சீ ரக தா  கர பெனா       
         வ  சிரா  நச  மா   -அ  தினா  
         கா  ச  தைலவ    க வ    ேபா லகி  
         வா  ச ம  ெதனேவ ைவ.                         (அ. ) 
Actions: 
ª Carminative 
ª Diuretic 
ª Anthelmintic 
ª Stomachic 
ª Emollient 
11. KARPOKARISI 
Botanical Name         : Psoralea corylifolia.Linn 
Family                       : Fabaceae                                
English Name            : Babchi Seeds 
Part Used                  : Seed 
Organoleptic characters: 
Taste       : Kaippu 
Potency   : Veppam 
Privu       : Kaarppu 
General properties: 
கா ேபாக மாமாிசி க டா  கர பா    
  ச வ ந சிைவேபா  பி த  டா -பா மீதி  
வாத கபநைம ச  வ ெசாறிசி ர  ம   
சீத மல   ழலா  ெச  .                 (அ. ) 
Actions: 
ª Laxative 
ª Stimulant                
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12.  BRAHMATHANDU VITHAI 
   Botanical Name         : Argemone Mexicana.Linn 
   Family                       :  Papaveraceae                
   English Name            : The maxican poppy;The Yellow thistle 
   Part Used                  : Seed 
Organoleptic Characters: 
 Taste        : Kaippu 
  Potency    : Veppam 
   Privu        : kaarppu 
General properties: 
  ேணா  கர பா  க சிர   சி விட க  
ச ணி ம  ேமகவளி த ேமக -அ ணி  
ப ேயா   மாவிட   ப ேநா  தீ   
  ேயா     டா  ைல  .                (அ. ) 
Actions: 
ª Laxative 
ª Sedative 


TRIAL DRUG
PRANGICHAKKAI CHOORANAM
NEERADIMUDHU PASAI
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STANDARD OPERATING PROCEDURES: 
Internal Medicine: PARANGICHAKKAI CHOORNAM 
Ingredients: 
1. Parangichakkai (Smilax china .Linn )   - 8 palam (280 Gms) 
2. Sivanar vembu (Indigofera aspalathoides.vahl ex DC ) - 4 palam (140 Gms) 
3. Changan verpattai (Azima tetracantha, Lam )  - 2 palam (70 Gms) 
4. Vellarugu (Enicostemma axillare.(Lam)Raynal )     - 2 palam (70 Gms) 
Source of trial medicine: 
           The raw drugs for the preparation of Parangichakkai Choornam and Neeradimuthu Pasai 
will be purchased from a well reputed country shop and the purchased drugs were authenticated 
by the authorities of Botany, National Institute of Siddha.. 
Method of preparation: 
 The purified Parangichakkai # is dried and made into choornam. Then the other three 
drugs such as Sivanar vembu (Indigofera aspalathoides.vahl ex DC), Changan ver pattai (Azima 
tetracantha, Lam), Vellarugu (Enicostemma axillare. (Lam) Raynal) were dried in sunlight and 
made into fine powder (choornam); and is mixed with the above parangichakkai choornam. 
Along with the choornam 10 palam (i.e 350 gm) sugar is mixed and it is kept inside the pot for 
10 days in Thaaniya pudam* 
Drug storage: 
       The trial drugs Parangichakkai Choornam (Int) is stored in clean plastic container and 
Neeradimuthu Pasai  (Ext) is stored in another clean plastic container. 
Dispensing: 
        The choornam is given in powder form in packets and paste is given in plastic container. 
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# PURIFICATION OF PARANGICHAKKAI: 
(Reference: Chikitcha Rathina Deepam; Page no117)   
Drugs used for purification of Parangichakkai: 
Sadura kalli (Euphorpia antiquorum. Linn.)  - 1 thookku (1.7 Kg) 
Thiruku kalli (Euphorpia tirucalli)   - 1 thookku (1.7 Kg) 
Sadurakalli and Thirukugalli are made into small pieces and are taken in one mud pot 
Then 21.44 litres. (16 Padi) water is poured into the pot and the mouth of the pot will be covered 
with thin cloth. The Parangichakkai will be made into small pieces and kept over .the cloth then 
it will be covered by another mud pot with the same size. This instrument is subjected to heat for 
6 hrs (Two Saamam) then allowed for boiling. Then the pieces of Parangichakkai are dried in 
shade then made into chooranam.  
____________________ 
* Thaaniya pudam: 
 It is a unique process mentioned in Siddha; in which the prepared medicines will be 
placed inside the cereals in a particular period especially paddy. After that only the medicines 
can be used for therapeutic purpose. 
EXTERNAL MEDICINE: 
NEERADIMUTHU PASAI:  
(Reference: Siddha Materia Medica – Medicinal plants division Page no 533-534).        
Ingredients: 
1. Neeradimuthu (Hydnocarpus laurifolia dennst. Sleumer) 
2. Kasakasaa (Papaver somniferum. Linn) 
3. Kopparai (Cocos nucifera) 
4. Kaattu seragam (Vernonia anthelmintica. Willd) 
5. Karunseragum (Nigella sativa.Linn) 
6. Karpogi vithu (Psoralea corylifolia.Linn) 
7. Brahmathandu vithai (Argemone mexicana.Linn) 
        - Equal quantity 
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Method of preparation: 
The above ingredients will be  made into powder and then will be mixed with Pulitha 
neer (Vinegar) and made into a paste. 
YOGAM TECHNIQUES TO BE USED FOR THE PATIENTS:  
· Meditative postures 
· Padmasanam 
· Vajrasanam  
· Pranayamam (Mathrika Pranayamam and Omkhara Pranayamam, Nithirai Pranayamam-
SOS) 
· Poorana shanthi Aasanam 
TRIAL DRUGS: 
           Internal medicine: PARANGICHAKKAI CHOORNAM 
                             (Reference: Chikitcha Rathina Deepam;  Page no117) 
           Dosage: 5 gm b.i.d 
           Adjuvant: Honey. 
           Duration: 30 days 
           External medicine: NEERADIMUTHU PASAI              
                             (Reference: Siddha materia medica - medicinal plants division;  Page 533-534) 
           Dosage:  Q.S  
STUDY DESIGN 
STUDY TYPE:  
Pilot study 
STUDY PLACE:  
Ayothidoss Pandithar Hospital,  
National Institute of Siddha, Chennai-47. 
STUDY PERIOD: 
                        12 months 
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 SAMPLE SIZE: 
            40 patients [20 OP + 20 IP]. 
Out of the 20 OP patients, 10 patients will be treat only with external medicines and 
remaining 10 will be treat with both internal and external medicines. Out of the 20 In-patients 10 
patients will be given Yogam treatment along with trial medicine and the remaining 10 will be 
given trail medicines only. 
SUBJECT SELECTION: 
         Patients reporting with symptoms of inclusion criteria will be subjected to screening test 
and documented using screening proforma . 
INCLUSION CRITERIA:  
o Age:20 -60.  
o Sex: Both Male and Female.  
o Typical distribution of the lesions on the face, axilla, body, inguinal regions and nails.  
o Well defined raised margin.  
o Marked itching.  
o Clearance in the central area of the lesion.  
o Willing to sign the informed consent stating that he/she will consciously stick to the 
treatment during 30 days but can opt out of the trial of his/her own conscious discretion      
o Willing to give blood and urine sample for laboratory investigations  
EXCLUSION CRITERIA:  
o Lesions with secondary infections  
o Deep type of Tinea barbae.  
o Any other systemic diseases  
o VDRL Positive cases 
o Diabetes  
o Hypertension  
o Leprosy 
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WITHDRAWAL CRITERIA 
· Intolerance to the drug and development of adverse reactions during drug trial. 
· Poor patient compliance & defaulters. 
· Patient turned unwilling to continue in the course of clinical trial. 
TESTS AND ASSESMENTS 
A. Clinical assessment  
B. Siddha assessment  
C. Routine investigation. 
a.  CLINICAL ASSESSMENT: 
· Site  
· Colour 
· Size 
· Shape 
· Border 
· Itching 
· Erythema 
· vesicles 
· Papule 
           b. ROUTINE INVESTIGATIONS: 
BLOOD 
Hb  
Total RBC Count  
ESR  
Blood sugar 
URINE 
         Urine sugar 
         Albumin 
         Deposits 
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                      c. RENAL  FUNCTION TESTS 
               Urea 
               Creatinine 
   Uric acid 
                  d. LIVER FUNCTION TESTS 
                 Serum total bilirubin 
                Direct bilirubin 
                Indirect bilirubin 
                Serum Alkaline phosphatases 
                 SGOT 
                 SGPT 
SIDDHA SYSTEM EXAMINATION: 
EN VAGAI THERVUGAL: 
                        1. Naadi 
                        2. Sparisam 
                        3. Naa 
                        4. Niram 
                        5. Mozhi 
                        6.Vizhi 
                        7. Malam 
                        8. Moothiram 
                                 Neikkuri: 
                             Neerkkuri: 
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METHODOLOGY
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     HISTORY TAKING 
LAB INVESTIGATION 
 TRIAL DRUG  
CLINICAL ASSESSMENT 
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INFORM ABOUT STUDY 
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ADVERSE DRUG REACTION 
ADVICED TO TAKE 
TREATMENT IN OPD 
ABNORMAL VALUES 
PHARMACOLOGICAL 
ASSESSMENT 
FURTHER MANAGEMENT OF 
ADVERSE DRUG REACTION 
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STUDY ENROLLMENT  
Patients reporting at the OPD with the clinical symptoms of Hyperpigmented elevated 
patches, itching, burning sensation etc will be examined clinically for enrolling in the study 
based on the inclusion and exclusion criteria.  
The patients who were enrolled would be informed (Form VI) about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms understandable to 
them. and informed consent would be obtained in writing from them in the consent form (Form 
VI).  
All these patients will be given unique registration card in which patients’ Registration 
number of the study, Address, Phone number and Doctors phone number etc. will be given, so as 
to report easily should any complications arise. 
Complete clinical history, complaints and duration, examination findings and laboratory 
investigations -- would be recorded in the prescribed Proforma. 
Screening Form- I will be filled up: Form –II and Form –III will be used for recording the 
patients’ history, clinical examination of symptoms and signs and laboratory investigations 
respectively. Patients would be advised to take the trial drug and appropriate dietary advice 
would be given according to the patients’ perfect understanding. 
CONDUCT OF THE STUDY: 
Purgation with Virechana Boopathy Tablet– 2 Nos early morning with hot water will be 
given for balancing the deranged mukkutram a day before treatment.  
The trial drugs Parangichakkai Choornam (Internal Medicine) and Neeradimuthu Pasai 
(External Medicine) are given for 30 days. OP patients should visit the hospital once in 7 days.  
At each clinical visit clinical assessment is done and prognosis is noted. For In Patients the trial 
drug is given for 30 days and the clinical assessment will be done daily. 10 In patients will be 
given Yogam treatment along with their internal medicines. The remaining 10 In patients will 
not be given Yogam treatment. The patients were advised to follow the specific dietary regimen 
during their treatment period. The results will be compared at the end of the study. Laboratory 
investigations are done 0 day & 30th day of the trial. For In patients, who are not in a situation to 
stay in the hospital for a long time, are advised to attend the OPD for further follow-up. Siddha 
investigations like Neer kuri and Nei kuri will be carried over. After the end of the treatment, the 
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patient is advised to visit the OPD for another 2 months for follow-up. If any trial patient who 
fails to collect the trial drug on the prescribed day but wants to continue in the trial from the next 
day or two, he/ she will be allowed, but defaulters of one week and more will not be allowed to 
continue and be withdrawn from the study with a fresh case being included. 
DATA COLLECTION FORMS: 
Required information will be collected from each patient by using the following forms. 
FORM l            : Screening Proforma  
FORM lI   : History taking Proforma  
FORM llI      : Clinical Assessment Proforma 
FORM lV    : Clinical assessment during & after Trial 
FORM V     : Laboratory Investigation Proforma 
FORM VI.a     : Information sheet  
FORM VI.b     : Consent Form 
FORM VI.c     :Dietary advice Form  
FORM VII       :Withdrawal Form 
 FORM VIII     :Drug compliance Form 
FORM IX         :Adverse reaction Form 
DATA ANALYSIS: 
After enrolling the patient in the study, a separate file will be maintained for each and 
every patient and all forms and other information will be kept in the file. The screening forms 
will be filed separately. All collected datas will be statistically analysed by Sr. Research Officer 
(Statistics) for logical errors and incompleteness of data to avoid any bias. No modification in the 
results is permitted for unbiased reports. Then final report will be generated. 
OUTCOME 
PRIMARY OUTCOME: 
Grade 1 : Turning to normal skin 
Grade 2 : Reduction of hyperpigmentation 
Grade 3 : Reduction of size and oozing 
Grade 4 : Reduction of itching 
Grade 5 : No improvement 
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SECONDARY OUTCOME:  
The effect of Drugs + Yogam --- 
Grade 1 : Turning to normal skin 
Grade 2 : Reduction of hyperpigmentation 
Grade 3 : Reduction of size and oozing 
Grade 4 : Reduction of itching 
Grade 5 : No improvement 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT:  
If the trial patient develops any adverse reactions, he/she would be immediately 
withdrawn from the trial and proper management will be given in OPD of National Institute of 
Siddha. 
ETHICAL ISSUES 
1. The internal drug was mentioned in the List of books of Drugs and Cosmetics Act 
1940. Hence no preclinical and toxicity studies will be carried out. 
2. The patient will be informed about the treatment and other procedures in his 
vernacular language. After getting the consent only (language understandable to the 
patient) they will be enrolled in the study.  
3. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of lab equipments 
will be used.                         
4. The data collected from the patient will be kept confidential.  
5. Treatment will be provided free of cost.  
6. If any adverse reactions occur it will be reported to the Pharmaco-vigilance 
committee of NIS. And they will be advised to take treatment at the OPD of National 
Institute of Siddha. 
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                          OBSERVATION AND RESULTS 
Results were observed with respect to the following criteria. 
1. Sex distribution  
2. Age distribution 
3. Kaalam distribution 
4. Noi utranilam 
5. Noi utrakaalam 
6.  Food habits 
7. Occupational status 
8. Socio economic status 
9. Mode of onset 
10. Aetiological factors 
11. Duration of illness 
12. Gunam 
13. Site of lesion 
14. Clinical features 
15. Mukkutra theory 
16. Udalthathukkal 
17. Ennvagaithervugal 
18. Neerkuri, Neikuri 
19. Gradation of results 
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1. GENDER DISTRIBUTION 
 
 
SL.  
No. Sex 
No. of Cases Percentage 
1. Male  28 69  %  
2. Female 12 31  %  
 
 
 
 
 
 
Inference: 
         Out of 42 patients; 69% belong to male and 31% belong to female. 
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2.AGE DISTRIBUTION 
 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
Among 42 patients 51% belong to 20-30 years, 31% belong to 31-40 years, 7% 
belong to 41-50 years and 9% belong to 51-55and 2% belong 55-60. 
 
SI. No. Age No. of Cases Percentage 
1. 20 - 30  22 5 1 %  
2. 31 - 40  13 3 1 %  
3. 41 – 50 3 7%  
4. 51 -55 4 9%  
5. 56 -60 1 2 % 
 TOTAL 42 100 % 
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3. KAALAM DISTRIBUTION 
 
 
 
 
Inference: 
Among 42 patients, 50% belong to vathakaalam, 50% pithakaalam. 
SI. No. Kaalam No. of Cases Percentage 
1. 
VathaKaalam 
(1-33 years) 
21 50%  
2. 
PithaKaalam 
(33-60 years) 
21  50%  
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4.  NOI UTRA NILAM: 
 
SI. No. Thinai No. of Cases Percentage 
1. Kurinji -  -   
2. Mullai -  - 
3. Marutham -  -  
4. Neithal 42 100% 
5. Paalai - - 
 
 
 
 
 
Inference: 
Among 42 patients, 100% of patient were from Neithalnilam. 
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5. NOI UTRA KAALAM: 
 
 
 
Inference: 
Among 42 cases, 62% of the cases had the onset of disease in Muthuvenir kaalam and 
38% of cases had the onset of disease in Kaar kaalam.  
SI.  
No. Paruvakaalam 
No.  
of Cases Percentage 
1. Kaarkaalam Aavani & Purataasi (Aug - Oct) 16  38 % 
2. Koothirkaalam Ippasi & Karthigai (Oct - Dec) - -  
3. Munpanikaalam  Markazhi & Thai(Dec - Feb) - - 
4. Pinpanikaalam Maasi & Panguni (Feb - Apr) - - 
5. Elavenilkaalam Chithirai & Vaikasi (Apr - Jun) -  -  
6. Muthuvenilkaalam  Aani&Aadi) (Jun - Aug)  26   62% 
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6.   FOOD HABITS: 
 
SI. 
No.  Food Habits No. of Cases Percentage 
1. Vegetarian 5 12%  
2.  Non vegetarian  37  88%  
 
 
 
Inference 
Out of 42 cases 12% belong to vegetarian diet and 88% belong to non-vegetarian diet. 
7.  SOCIO ECONOMIC STATUS: 
 
SL.No Socio Economic Status No. of cases Percentage 
1 Poor 10 14% 
2 Middle class 16 38% 
 3 Rich  16 38% 
 
Inference:  
Out of 42 patients, 14% of cases belong to poor socio economic status and 38% of 
cases belong to Moderate class38 % belongs to rich. 
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8. OCCUPATIONAL STATUS: 
SL. 
NO OCCUPATION No.OF CASES PERCENTAGE 
1 Student  6 15% 
2 Home maker  8 19% 
3 Coolie 3 7% 
4 Software 3 7% 
5 Business 5 12% 
6 Painter  2 5% 
7 Mech.operator 2 5% 
8 Yoga teacher 1 2% 
9 Accountant  1 2% 
10 Cylinder carrier 1 2% 
11 Sales executive 2 5% 
12 Vector controller 1 2% 
13 Postman  1 2% 
14 Unemployee 6 15% 
 
Inference 
Among  42 cases  15% belong to Student,19%belong to Home maker, 7% belong to 
coolie ,7%belong to Software,12% belong to Business,5% belong to Painter 5% belong to 
Mech.operator,2% belong to Yoga teacher,2%belong to Accountant,2%belong to Cylinder 
carrier,5% belong to Sales executive,2%belong to Vector controller,2%belong to Postman 
and 15% Unemployees. 
 
72 
 
9. MODE OF ONSET 
SL. No Mode of onset No of cases Percentage 
1 Sudden 6 14% 
2 Gradual 36 86% 
 . 
Inference: 
Out of 42 cases, the mode of onset is Sudden in 14% of the cases and gradual onset in 
86% of the case. 
10.   ETIOLOGICAL FACTORS: 
SL. No  Etiological factors No of cases Percentage 
1 Personal hygiene  30  71% 
2 Close contact with affected persons 1 2 29% 
 
 
 
Inference 
Among 42 cases, 71% had the etiology of poor personal hygiene and 29% had history of close contact with 
affected persons. 
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11. DURATION OF ILLNESS: 
SL. No Duration No. of Cases Percentage 
1. 1 week 2 5% 
2. 3 weeks 2 5% 
3. 1 – 6  month 18 42% 
4. 6 month – 1 year 4 10% 
5. 2 years 4 10% 
6 3 years 4 10% 
7 4 years 1 2% 
8 5 years 1 2% 
9 More than 5 years 6 14% 
 
 
 
Inference: 
Among 42 cases, 5% patients suffered for 1 week,5% patients suffered for 3 
week,42% of cases suffered for 1-6 months, 10% of cases for 6 months to 1 year, 10% of 
cases for 2 years, 10% of cases for 3years, 2% of cases for 4 years and 2% of casessuffered 
for 5 years and 14% patients suffered for more than 5 years. 
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12. GUNAM: 
SI. No. Gunam No. of Cases Percentage 
1. Sathuvagunam - - 
2. Rajogunam 42 100 % 
3. Thamogunam - -  
 
.Inference: 
100% of cases had Rajogunam. 
13. SITE OF LESION 
SL. No. Site of lesion No. of Cases Percentage 
1. Waist, lower abdomen, hip, thigh, glulteal and groins   
30   71% 
2. Upper limb & lower limb 2 5%  
3. Axilla,trunk 4  10%  
4. Neck & shoulder 6 14%  
 
.  
Inference: 
Out of 42 cases 71% cases had lesion in waist,lower abdomen,hip,thigh, glulteal and 
groins.5%had lesion in Upper limb & lower limb,10% in Axilla,trunk,14% in Neck & 
shoulder region. 
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14. CLINICAL FEATURES 
SI. No. Clinical features No. of Cases Percentage 
1. Itching 42 100% 
2. Border well defined 42 100% 
3. Erythema 40 95% 
4. Hyperpigmentation 38  90% 
5. Vesicles 10 23% 
 
 
 
 
Inference: 
Out of 42 cases, 100% had itching, 100% had well defined border, 95% had erythema, 
10% had vesicle 90% had pigmentation.  
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15. THRI THODAM THEORY 
 According to the Siddha theory, the three chief constituents of the body vatham, 
pitham and kabam and its classification changes from the normal phenomenon and causes 
pathological state due to varied aetiology. Hence the derangement of doshams in 
Pundareegakuttam   is tabulated as follows. 
a) Table illustrating the derangement of Vatham:  
 
SL. No. Classification of Vatha No. of Cases Percentage 
1. Pranan - - 
2. Abanan  -  - 
3. Udhanan  -  - 
4. Samanan 42 100% 
5. Viyanan 42 100% 
6. Nagan - - 
7. Koorman  -          - 
8. Kirukaran - - 
9. Devathathan -  - 
10. Dhananjayan - - 
 
Inference: 
Among 42 patients, 100% of cases had deranged viyanan and samanan.  
b) Table illustrating the derangement of Pitham: 
SL .No. Classification of Pitham No. of Cases Percentage 
1. Anarpitham  -   - 
2. Ranjagam -   - 
3. Sathagam -   - 
4. Alosagam  -  - 
5. Prasagam  42 100% 
Inference 
Among 42 patients, 100% of cases had deranged prasagam 
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16. UDALTHATHUKKAL 
 
 
 
 
 
 
Inference: 
Out of 42 cases, 100% of the cases had derangement in saaram and senneer. 
17.  EN VAGAI THERVUGAL 
SL . No. EnnvagaiThervugal No. ofCases Percentage 
1. Naadi   
        Vatha Pitham 20 48 % 
         Pitha Vatham 7 16 % 
         Vatha Kapham 12 29 % 
         Pitha kabam 1 2% 
2. Sparisam - - 
3. Naa - - 
4. Niram 40 100% 
5. Mozhi - - 
6. Vizhi - - 
7. Malam - - 
8. Moothiram - - 
Inference: 
48 % of the cases had VathaPitham. 16% of the cases had Pitha Vatham 29 % of the 
cases had Vatha Kapham 2% of the cases had Pithakabam. 
SL .No. Udalthathukkal 
 
No. of Cases Percentage 
1. Saaram 42 100% 
2. Senneer 42 100% 
3. Oon - - 
4. Kozhuppu - - 
5. Enbu - - 
6. Moolai - - 
7. Sukkilam / Suronitham - - 
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18. NEERKURI, NEIKURI  
SL. No. Type of Test No. of Cases Percentage 
1. Neerkuri :       Straw colored urine             18 100% 
   2. 
Neikuri            Iyya Neer 
                         Vali Neer 
                         Azhal Neer 
           
          16 
            
           2 
           - 
 
88% 
     
        12% 
          - 
 
Inference: 
  Out of 18 cases, 100% of the cases had Straw coloured urine. 88% had shown Iyya 
Neer,2% had shown Vali Neer. 
19. A. GRADATION OF RESULTS. 
SL. No. Grade No.  of Cases Percentage 
  1 Grade – 1 Turning to normal skin            -           - 
  2 Grade – 2  Reduction of hyperpigmentation          30          71% 
  3 Grade – 3 Reduction of size and oozing           10          24% 
  4 Grade – 4  Reduction of itching           2           5% 
  5 Grade – 5 No improvement            -            - 
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40.00%
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80.00%
GRADE -
1
GRADE -
2
GRADE -
3
GRADE -
4
GRADE -
5
0.00%
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24.00%
5.00% 0%
GRADATION OF RESULTS
GRADE -1
GRADE -2
GRADE - 3
GRADE - 4
GRADE - 5
 
Inference: 
Out of 42 cases results of 71% cases were Grade - 2 (Reduction of hyper 
pigmentation), 24% of the cases were Grade – 3 (Reduction of size and oozing) and 5% of 
the cases were Grade – 4 (Reduction of itching). 
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B.GRADATION OF RESULT WITH YOGA:   
SL. No. Grade No. of Cases Percentage 
  1 Grade – 1 Turning to normal skin            -           - 
  2 Grade – 2 Reduction of hyperpigmentation           7          74% 
  3 Grade – 3 Reduction of size and oozing            3          26% 
  4 Grade – 4  Reduction of itching           -           - 
  5 Grade – 5 No improvement            -            - 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inference: 
        Out of 10 patients 74% cases were Grade-2 (Reduction of hyperpigmentation), 26% of 
the cases were Grade – 3 (Reduction of size and oozing). 
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LIST OF OUT PATIENTS  BEFORETREATMENT : 
S 
No Pt No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
1 C 92828 Mr. John Kannan 52 – M 13.1 6600 68 27 5 4.1 14 / 32 91 105    - 17 0.5 Nil Nil 2-4 2-4 
2 C 64146 Miss. Sudha 23 – F 12 7400 59 30 11 4 6 / 12 92    -    - 14 0.4 Nil Nil 4-5 4-5 
3 C 92019 Mr. Kumar 40 – M 13.4 8200 58 36 4 4.7 2 / 4 109    -    - 22 0.6 Nil Nil 2-4 1-2 
4 C 91410 Mrs. Ramalakshni 40 – F 12.7 8700 69 27 4 3.9 6 / 12 106     - 17 0.5 Nil Nil 1-2 1-2 
5 C 30763 Mr. Ranjith Kumar 27 – M 14.7 7000 59 36 5 4.5 2 / 6 108 127  21 0.6 Nil Nil 2-4 2-4 
6 C 78775 Mr. Siva Subramaniyam 33 – M 15.3 6600 69 25 6 4.8 2 / 6     -    - 90 23 0.7 Nil     - 1-2 2-3 
7 C 72487 Mr. Raj 40 – M 14.8 5600 64 29 7 4.9 2 / 6     -    - 97 19 0.7 Nil Nil 1-2 2-4 
8 C 68940 Mrs. Mubeen Sultana 40 – F 11.8 6800 65 30 5 4.4 2 /4     -    - 111 20 0.7 Nil Nil 2-4 2-4 
9 C 70211 Mrs. Yasmin 34 – F 11.7 9200 75 20 5 4.1 6 /16     -    - 78 14 0.5 Nil Nil 3-4 4-5 
10 C 80444 Mr. Sriram 23 – M 14 9500 59 33 8 4.8 4 /8 100 130  23 0.7 Nil Nil Nil Nil 
11 C 97004 Mr. Murgan 27 – M 15.3 7900 43 53 4 4.5 2 / 6     -    - 101 14 0.4 Nil Nil 2-4 2-4 
12 C 84357 Mrs. Chitra 38 – F 12.6 5000 66 29 5 4.3 4 /12 94 123  16 0.5 Nil Nil 1-2 2-3 
13 D 16  Mr. Maharaj 20 – F 15.1 8500 75 21 4 5.1 2 /4    -    - 78 14 0.4 Nil Nil    -   - 
14 C 99266 Mr. Balamanikandan 20 – M 16.3 6900 60 37 3 4.8 2 /4    -    - 82 23 0.7 Nil Nil     -    - 
15 C 93334 Mr. Elumalai 34 – M 14.1 6000 56 39 5 5.1 2 /8 108 140  14 0.4 Nil Nil 2-4 2-4 
16 D 1799 Mr. Sasivijay 36 – M 14.6 8400 60 33 5 4.9 2 /4 82 106  27 0.8 Nil Nil 1-2 1-2 
17 C 82615 Mrs. NameethaBanu 36 – F 10.2 8500 60 36 4 4.7 6 / 12 88 116  19 0.6 Nil Nil 2-4 2-4 
18 C 85452 Mr. Kumaresan 27 – M 16.1 6800 66 30 4 5.2 2 / 4    -    - 96 20 0.7 Nil Nil 2-4 2-4 
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S 
No Pt No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
19 C 77901 Mr. Selvam 45 – M 14.2 7300 71 22 7 5.3 2 / 4    -    - 102 39 0.9 Nil Nil 2-4 2-4 
20 C 94150 Mr. Nagaraj 23 - M 17.1 10400 66 30 4 5.7 2 / 6 83 116 89 30 0.8 Nil Nil 2-4 2-4 
21 C 62685 Mr. Suresh 27 – M 15.1 11200 66 30 4 5.1 6 /14    -    - 108 14 0.4 Nil Nil 2-4 1-2 
22 C 82772 Mr. Maheshkumar 23 – M 15.4 7700 39 49 1 5.4 2 /4 80 104      - 16 0.5 Nil Nil 1-2 2-3 
23 C 82618 Mr. Jalaludeen 42 – M 16 9800 61 32 7 5.4 2 /4    -    - 85 30 0.9 Nil Nil 1-2 1-2 
24 AQ6949 Mr. Gopikrishna 23 - M 15.9 5700 56 41 3 4.9 2 /6 80 90    - 15 0.5 Nil Nil 1-2 1-2 
25 C 80305 Mr. Dhanagopal 24 – M 16.2 6700 58 37 5 5.8 2 /6 76 109    - 20 0.7 Nil Nil 1-2 2-3 
26 C 74783 Mrs. Anbukarasi 46 – F 13.3 8200 65 31 4 4.3 42 /84 73 84    - 18 0.6 Nil Nil 2-4 2-4 
27 C 88582 Miss. LenyJannet 22 – F 13.3 14700 75 20 5 4.5 4 /16    -     - 91 16 0.5 Nil Nil 1-2 1-2 
28 C 58591 Mr. Selvam 40 – M 16.4 6600 59 36 5 5.3 2 /4 92 107   - 17 0.5 Nil Nil 3-4 2-4 
29 C 79617 Mrs. Gajalakshmi 40 - F 12.9 9500 63 33 4 4.5 2 /4    -    - 116 18 0.6 Nil Nil 1-2 2-3 
30 C 88672 Mr. Seenu 22 – M 16 8500 55 37 8 5.2 2 /4    -     - 90 21 0.7 Nil - 3-4 2-3 
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LIST OF OUT PATIENTS AFTER TREATMENT : 
S 
No Pt No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
1 C 92828 Mr. John Kannan 52 – M 13.6 6700 65 25 5 4.2 6 / 12 98 110    - 16 0.4 Nil Nil 1-2 1-3 
2 C 64146 Miss. Sudha 23 – F 12.5 8500 66 30 4 4.1 10 / 34 84   -    - 16 0.5 Nil Nil 1-2 1-2 
3 C 92019 Mr. Kumar 40 – M 12.8 8400 62 39 3 4.8 1 / 2    -    - 98 20 0.5 Nil Nil 1-2 1-3 
4 C 91410 Mrs. Ramalakshni 40 – F 12.6 8800 67 25 5 4.2 3 / 6 102   -       - 18 0.3 Nil Nil 1-2 1-2 
5 C 30763 Mr. Ranjith Kumar 27 – M 14.6 7200 62 37 4 4.4 1 / 3 104 124    - 18 0.3 Nil Nil 1-2 1-2 
6 C 78775 Mr. Siva Subramaniyam 33 – M 15.2 9400 72 26 2 4.7 4 /10    -    - 100 20 0.9 Nil Nil 1-2 2-4 
7 C 72487 Mr. Raj 40 – M 15.3 6100 55 38 7 5.1 4 / 8 110 119    - 14 0.4 Nil Nil 2-4 2-4 
8 C 68940 Mrs. Mubeen Sultana 40 – F 12.1 6900 83 14 3 4.5 6 /14    -   - 110 19 0.8 Nil Nil 1-2 2-3 
9 C 70211 Mrs. Yasmin 34 – F 12.3 9600 72 20 6 4.3 3 / 6    -    - 92 14 0.4 Nil Nil 1-2 1-2 
10 C 80444 Mr. Sriram 23 – M 14.2 9400 62 38 5 4.5 2 / 4     -     - 90 29 0.9 Nil Nil Nil Nil 
11 C 97004 Mr. Murgan 27 – M 15 8000 46 42 6 4.3 1 /3     -     - 98 18 0.3 Nil Nil 1-2 2-3 
12 C 84357 Mrs. Chitra 38 – F 13.2 5700 70 25 5 4.5 4 / 8 101     -  14 0.4 Nil Nil 1-2 2-3 
13 D 16  Mr. Maharaj 20 – F 16 8900 49 20 5 5.2 1 /2     -     - 80 16 0.5 Nil Nil    -   - 
14 C 99266 Mr. Balamanikandan 20 – M 16 6800 62 38 5 4.9 1 / 2     -    - 89 24 0.5 Nil Nil     -    - 
15 C 93334 Mr. Elumalai 34 – M 14.4 6200 58 40 5 5.6 1 /2 100 128  14 0.3 Nil Nil 2-4     - 
16 D 1799 Mr. Sasivijay 36 – M 14.4 8900 63 30 8 4.6 1 /2     -     - 98 32 0.7 Nil Nil 1-2 1-2 
17 C 82615 Mrs. NameethaBanu 36 – F 10.8 9700 61 36 3 4.9 3 /6     -     - 80 22 0.5 Nil Nil 1-2 1-2 
18 C 85452 Mr. Kumaresan 27 – M 15.6 6400 63 33 4 4.9 2 / 4     -     - 101 19 0.5 Nil Nil 1-2 1-2 
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S 
No Pt No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
19 C 77901 Mr. Selvam 45 – M 14 9200 58 30 5 5.3 3 /6 98 111   - 30 0`7 Nil Nil 1-4   - 
20 C 94150 Mr. Nagaraj 23 - M 16.4 8400 66 28 6 5.4 1 / 3 94 110 86 32 0.9 Nil Nil 1-2 1-2 
21 C 62685 Mr. Suresh 27 – M 15 11000 65 32 6 5.4 3 /6    -    - 108 12 0.3 Nil Nil 1-2 2-3 
22 C 82772 Mr. Maheshkumar 23 – M 15 8000 42 28   - 4.8 1 /2    -    - 94 19 0.6 Nil Nil 1-2    - 
23 C 82618 Mr. Jalaludeen 42 – M 15.8 9000 58 39 3 5.3 2 / 4    -    - 82 19 0.5 Nil Nil 1-2 1-2 
24 AQ6949 Mr. Gopikrishna 23 - M 16.8 5900 55 39 6 5.1 2 / 4 103 121  14 0.4 Nil Nil 2-4 3-5 
25 C 80305 Mr. Dhanagopal 24 – M 16 7200 62 39 6 4.9 2 /3    -    - 94 36 0.3 Nil Nil    - 1-3 
26 C 74783 Mrs. Anbukarasi 46 – F 12.5 6200 58 39 3 4.1 6 /20 92 100  14 0.4 Nil Nil 1-2 1-2 
27 C 88582 Miss. LenyJannet 22 – F 13.6 14600 60 25 6 4.4 2 /8    -    - 100 18 0.3 Nil Nil 1-2 1-3 
28 C 58591 Mr. Selvam 40 – M 16.2 6800 60 35 6 5.4 1 /2    -    - 92 18 0.4 Nil Nil 3-4 1-2 
29 C 79617 Mrs. Gajalakshmi 40 - F 12.3 8600 68 35 5 4.4 1 /2    -    - 110 19 0.7 Nil Nil - 1-2 
30 C 88672 Mr. Seenu 22 – M 15.8 8800 56 39 7 5.4 1 /2    -    - 92 23 0.5 Nil - 1-2 2-3 
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LIVER FUNCTION TESTS 
S 
No Pt No Name 
Tot  Bilirubin DirBilurubin IndBilurubin SGOT SGPT ALP 
BF AF BF AF BF AF BF AF BF AF BF AF 
1 C 92828 Mr. John Kannan 0.5 0.4 0.2 0.3 0.3 0.2 10 28 9 18 130 186 
2 C 64146 Miss. Sudha 0.3 0.4 0.2 0.2 0.1 0.2 32 17 24 19 175 161 
3 C 92019 Mr. Kumar 0.5 0.8 0.2 0.1 0.3 0.2 30 32 31 34 179 186 
4 C 91410 Mrs. Ramalakshni 0.5 0.4 0.2 0.1 0.3 0.5 14 16 15 18 140 185 
5 C 30763 Mr. Ranjith Kumar 0.4 0.5 0.2 0.1 0.2 0.2 21 20 23 26 152 184 
6 C 78775 Mr. Siva Subramaniyam 0.8 0.6 - - - - 17 28 18 20 212 168 
7 C 72487 Mr. Raj 0.6 0.6 0.2 0.2 0.1 0.4 29 12 30 13 169 146 
8 C 68940 Mrs. Mubeen Sultana 0.7 0.5 - - - - 19 25 20 26 184 158 
9 C 70211 Mrs. Yasmin 0.5 0.5 0.2 0.2 0.1 0.3 43 18 36 17 187 160 
10 C 80444 Mr. Sriram 0.4 0.5 - - - - 30 36 56 32 197 186 
11 C 97004 Mr. Murgan 0.8 0.7 0.5 0.6 0.3 0.2 16 18 18 21 165 186 
12 C 84357 Mrs. Chitra 0.5 0.6 0.2 0.2 0.3 0.4 30 29 35 30 196 158 
13 D 16  Mr. Maharaj 0.7 0.6 0.3 0.2 0.4 0.3 15 18 17 16 175 184 
14 C 99266 Mr. Balamanikandan 1.9 1.8 0.7 0.6 1.2 1.0 24 26 26 28 185 187 
15 C 93334 Mr. Elumalai 0.6 0.5 0.2 0.4 0.4 0.2 13 12 15 13 146 142 
16 D 1799 Mr. Sasivijay 0.5 0.6 0.2 0.1 0.1 0.2 28 32 16 30 152 182 
17 C 82615 Mrs. NameethaBanu 0.4 0.3 0.2 0.4 0.2 0.5 15 21 18 28 240 180 
18 C 85452 Mr. Kumaresan 0.6 0.4 0.3 0.2 0.3 0.2 16 28 17 29 145 149 
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S 
No Pt No Name 
Tot  Bilirubin DirBilurubin IndBilurubin SGOT SGPT ALP 
BF AF BF AF BF AF BF AF BF AF BF AF 
19 C 77901 Mr. Selvam 0.6 - 0.2 - 0.4 - 24 - 25 - 136 - 
20 C 94150 Mr. Nagaraj 0.8 0.8 0.9 0.6 0.8 0.5 28 25 30 27 90 150 
21 C 62685 Mr. Suresh 0.5 0.6 0.2 0.1 0.3 0.2 30 28 31 25 180 182 
22 C 82772 Mr. Maheshkumar 0.5 0.4 0.2 0.1 0.3 0.2 14 19 15 23 166 186 
23 C 82618 Mr. Jalaludeen 0.5 0.5 0.2 0.2 0.3 0.3 17 21 19 22 159 143 
24 AQ6949 Mr. Gopikrishna 0.9 0.9 0.3 0.3 0.6 0.6 24 25 25 26 198 168 
25 C 80305 Mr. Dhanagopal 0.6 0.3 - 0.2 - - 41 38 39 30 204 184 
26 C 74783 Mrs. Anbukarasi 0.3 0.4 0.2 0.2 0.1 0.2 18 20 20 22 219 177 
27 C 88582 Miss. LenyJannet 0.6 0.5 0.2 0.3 0.4 0.3 12 16 14 18 143 168 
28 C 58591 Mr. Selvam 0.5 0.3 0.2 0.1 0.3 0.3 23 28 25 28 175 178 
29 C 79617 Mrs. Gajalakshmi 0.8 0.6 - - - - 10 34 15 38 40 184 
30 C 88672 Mr. Seenu 0.4 0.2 0.2 0.1 0.2 0.2 30 32 31 38 187 158 
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LIST OF IN PATIENTS BEFORE TREATMENT: 
S 
No IP No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
1 5012 Mr. Balaji 22 - M 15.8 7100 65 25 10 5.5 4 / 8     -   - 81 32 0.9 Nil Nil    -  - 
2 3290 Mr. Balakrishnan 52 – M 14.7 6700 60 32 8 4.5 6 / 14 104 131   - 22 0.7 Nil Nil 2- 4 1- 3 
3 5050 Mr. Tamilarasan 20 – M 13.6 6200 56 28 8 4 2 / 8 82 99   - 18 0.7 Nil Nil 1-2 2-4 
4 5035 Mr. Rajan 58 – M 13.3 9000 63 32 5 4.6 2 / 4 81 96   - 32 0.8 Nil Nil 2-4 2-4 
5 5014 Mr. Rajkamal 23 – M 14.6 5400 42 47 11 4.7 2 / 6   -   - 92 31 0.9 Nil Nil   -   - 
6 4975 Mr. Karthick 20 – M 13.7 12000 70 25 5 5.1 4 / 10 72 83   - 21 0.6 Nil Nil   -   - 
7 5049 Mr. Shanmugam 22 – M 15.3 5200 61 34 5 5.3 4 / 8 99 120  15 0.4 Nil Nil 2-4 2-4 
8 5006 Mr. Periyasami 22 – M 15.3 6700 60 44 6 5 2 / 4    -   - 98 14 0.4 Nil Nil 1-2 2-4 
9 5780 Mr. Muniyandi 54 – M 13.8 5800 58 43 5 7 6/12 100 123   - 15 0.6 Nil Nil 2-3 2-4 
10 5034 Mr. Rahul 21 – M 16.2 8300 68 26 6 5.1 2 / 4 85 114   - 15 0.4 Nil Nil 1-2 1-2 
11 4053 Mrs. Jeyanthi 40 – F 9.3 6900 68 24 6 4.2 2 / 6 83 112   - 17 0.6 Nil Nil 1-2 1-2 
12 4949 Mr. BanerjiRao 60 – M  12.8 7200 60 36 4 4.2 2 / 4 87 103   - 21 0.6 + + Nil 2-4 2-4 
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LIST OF IN PATIENTS AFTER TREATMENT: 
S 
No Pt No Name 
Age / 
Sex 
Hb 
gm/dl 
T.WBC 
cu/mm 
DC cells/cumm Total  
RBC 
ESR 
½ hr 
Blood sugar BUrea 
mg / dl 
S 
creatinine 
mg / dl 
Urine Deposit 
P L E F PP RN Alb Sug PC EC 
1 5012 Mr. Balaji 22 - M 15.2 7800 66 28 6 5.4 2 / 4    -    - 96 36 0.7 Nil Nil    -    - 
2 3290 Mr. Balakrishnan 52 – M 14.9 7200 68 35 4 5.1 2 / 6    -    - 98 28 0.9 Nil Nil 1-3 1-2 
3 5050 Mr. Tamilarasan 20 – M 9.8 6000 55 39 5 4.2 1 / 4 93 103    - 21 0.6 Nil Nil 1-2 2-3 
4 5035 Mr. Rajan 58 – M 13 9200 60 30 6 4.3 2 / 2 90 109    -  30 0.8 Nil Nil 2-4 1-2 
5 5014 Mr. Rajkamal 23 – M 14.2 6200 38 42 11 4.9 1 / 3    -    - 98 32 0.8 Nil Nil    -    - 
6 4975 Mr. Karthick 20 – M 12.8 12000 72 25 4 5.2 2 / 5 75 100    - 22 0.8 Nil Nil    -    - 
7 5049 Mr. Shanmugam 22 – M 14.6 6300 60 35 5 4.9 2 / 10 88 106    - 17 0.8 Nil Nil 2-3 1-2 
8 5006 Mr. Periyasami 22 – M 15 7000 66 46 5 4.8 1 / 2    -    - 103 16 0.5 Nil Nil 1-2    - 
9 5780 Mr. Muniyandi 54 – M 15 6780 65 45 5 4.9 1/2 98 120    - 15 0.6 Nil Nil 1-4 1-3 
10 5034 Mr. Rahul 21 – M 15.8 8200 67 28 5 5 1 / 2 86 110    - 14 0.2 Nil Nil 1-2 2-4 
11 4053 Mrs. Jeyanthi 40 – F 9.2 6800 62 29 9 4.4 1 / 6 96    -    - 22 0.9 Nil Nil 1-2 2-3 
12 4949 Mr. BanerjiRao 60 – M  11.5 6800 55 42 3 4.5 6 / 16 102 112    - 20 0.5 + Nil 2-4 2-4 
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LIVER FUNCTION TESTS 
S No Pt No Name Tot  Bilirubin DirBilurubin IndBilurubin SGOT SGPT ALP BF AF BF AF BF AF BF AF BF AF BF AF 
1 5012 Mr. Balaji 0.5 0.4 0.2 0.3 0.3 0.5 30 32 31 35 185 186 
2 3290 Mr. Balakrishnan 0.6 0.5 0.2 0.2 0.4 0.3 30 28 34 32 198 185 
3 5050 Mr. Tamilarasan 0.8 0.9 0.5 0.5 0.2 0.2 28 18 30 21 190 184 
4 5035 Mr. Rajan 0.5 0.6 0.2 0.1 0.3 0.3 16 17 17 16 151 160 
5 5014 Mr. Rajkamal 0.6 0.5 0.2 0.1 0.4 0.2 15 16 16 18 152 184 
6 4975 Mr. Karthick 0.5 0.7 0.2 0.3 0.3 0.5 12 18 16 19 254 240 
7 5049 Mr. Shanmugam 0.6 0.4 0.2 0.2 0.4 0.2 18 28 19 29 170 176 
8 5006 Mr. Periyasami 1.3 0.8 0.7 0.8 0.6 0.3 28 35 31 28 178 186 
9 5780 Mr. Muniyandi 0.9 0.7 0.6 0`8 0.5 0.5 30 30 28 29 177 180 
10 5034 Mr. Rahul 1.1 1.0 0.5 0.4 0.6 0.5 52 54 66 66 117 118 
11 4053 Mrs. Jeyanthi 0.7 0.9 0.2 0.5 0.2 0.6 31 36 24 28 194 185 
12 4946 Mr. BanerjiRao 0.5 0.3 0.2 0.1 0.3 0.3 29 28 28 27 176 160 
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DISCUSSION 
  The clinical entity of Padar Thamari is more or less similar to that of Tinea infection 
in modern medicine. It is a dermatological condition which is characterized by  
hyperpigmented well defined patch or patches of scaling, vesicles and pustules with 
inflammation most marked at the periphery of the lesion and the lesions are spreading in 
nature like an orbicular lotus leaf. Anatomy and physiology of skin and aetiology, clinical 
features etc., of the disease are discussed. 
 Author collected information largely from ‘Siddha Maruthuvam – Sirappu’, 
‘Gurunaadi nool’, ‘Dhanvanthri Vaidhyam’ and ‘Agathiyar Kanma Kaandam’ in which the 
Siddha methods of diagnosis have been dealt with. Before and after the course of treatment, 
the patients were subjected to laboratory investigations and photographs were taken. 
ETIOLOGY: 
The causative factors of the disease can be found out from the history given by the 
patients, their diet, habits, occupation, mental stress and other signs and symptoms. The 
present study shows the disease is caused due to poor hygiene. 
GENDER DISTRIBUTION: 
  Out of 42 patients 69% belongs to male 31% belongs to female.  
AGE DISTRIBUTION: 
             Among 42 patients 51% belongs to 20-30 years, 31% belongs to 31-40 years, 7% 
belongs to 41-50 years, 9% belongs to 51- 55 years,2% belongs to 55-60 years 
DIETARY HABITS: 
 Out of 42 cases 12% belongs to vegetarian diet and 88% belongs to non-vegetarian 
diet. 
 KAALAM DISTRIBUTION:  
             Among 42 cases 50% belong to Vatha kaalam 50% belong to Pitha kaalam. 
OCCUPATIONAL DISTRIBUTION: 
             Among 42 cases 15% belongs to student,19% belongs to home maker,7% belongs to 
software,12% belongs to mech. Operator,2% belongs to yoga teacher, 2% belongs to 
cylindrical carrier,5% belongs to sales executive,2% belongs to vector controller, 2% belongs 
to postman,15% are unemployees. 
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SOCIO-ECONOMIC DISTRIBUTION: 
           Among 42 cases 14% belongs to poor socio economic status,38% belongs to 
moderate,38% belongs to rich socio economic status. 
MODE OF ONSET: 
           Out of 42% cases 14% are sudden onset,86% are of gradual onset 
ETIOLOGICAL DISTRIBUTION:                                                                                       
              Out of 42 patient 71% are affected by personal hygiene,29% by close contact. 
DURATIONAL DISTRIBUTION: 
              Among 42 cases 5% are suffered for 1 week,5% for 3 week,42% for 1-6 
months,10% for 2years,10% for 3years,2% for 4 years,2% for 4 years,14%for more than 5 
years. 
SYMMETRY DISTRIBUTION:  
             5% in upper and lower limb,7% in waist,hip thigh gluteal region,10% in axilla, 
trunk,14% in neck and shoulder  
NOI UTRA KAALAM: 
           Among 42 cases, 62% of the cases had the onset of disease in Muthuvenir kaalam and 
38% of cases had the onset of disease in Kaar kaalam.  
NOI UTRA NILAM: 
Among 42 cases, 100% of patients were admitted to the trial from neithal.    
REFERENCE OF MUKKUTRAM 
1. VATHAM 
               Viyanan and Samanan were affected in all the cases (100%).   
2. PITHAM 
In all the 42 (100 %) patients, Prasakam was affected. Prasakam is responsible for the 
complexion of the skin. 
3. KABAM 
Changes reported in kabam in all the 42 patients. 
UDAL KATTUGAL: 
Saaram and Senneer which are responsible for the colour of the skin were affected in 
all the 42 (100 %) cases. 
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ENVAGAI THERVUGAL: 
               Niram was affected in all the 42 (100 %) cases.   
GRADATION OF RESULTS AFTER TREATMENT: 
           Out of 42 cases results of 71% cases were Grade – 2(Reduction of 
hyperoigmentation), 24% of the cases were Grade – 3(Reduction of size and oozing) and 5% 
of the cases were Grade – 4(Reduction of itching). 
GRADATION OF RESULTS WITH YOGA: 
         Out of 10 patients 74% cases were Grade –2(Reduction of hyperpigmentation), 26% 
of the cases were Grade – 3(Reduction of size and oozing). 
 MANAGEMENT: 
                             ‘Viresanathaal vatham thaazhum’ 
 In Siddha System before starting the treatment it is necessary to bring the Mukkutram 
to equilibrium. By giving purgation vitiated vatham come to normal condition.                                     
.            I DAY  - Virechana Boopathi Tablet -2  O.D given in the early morning. 
DRUGS:    
             II DAY -Internal Medicine: Parangichakkai chooranam – 5gms with honey 
             External Medicine: Neeradimuthu Pasai  
             Patients were instructed to take the medicines regularly and apply the external 
medicine twice a day. It was ensured that the diet restrictions imposed were followed 
properly by the patients. 
             These specific drugs for the dissertation work were prepared by the author in the 
supervision of Faculty members of Gunapadam in the Gunapadam practical laboratory,  
National Institute of Siddha. Bio-chemical Analysis was also done in the Bio chemistry 
laboratory of National Institute of Siddha. 
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SUMMARY 
· Padar Thamarai has been chosen for the dissertation work by the author. Various 
literatures have been collected from Siddha and modern literatures. 
· Preclinical analyses in biochemical aspects was conducted for the trial drug Parangi 
chakkai chooranam. 42 patients of both sex and in age group between 20 to 60 were 
selected for the study. 
· 12 cases were treated in Inpatient ward at least for minimum 15 days and followed up in 
the outpatient department after discharge. 30 cases were treated in the outpatient 
department for 30 days. 
· All the details about the study and the drugs were informed to the patients in their 
vernacular language and consent forms duly signed by them were obtained from them.  
Before starting the treatment, the blood samples of the selected patients were subjected to 
investigation and photographs of the lesions were taken. 
· A day before starting the treatment purgation was given by administering Virechana 
Boopathi Tablet - 2 O.D with hot water in the early morning to normalise the 
thrithodam.  
· From the second day onwards Parangichakkai chooranam – 5gms B.I.D. along with 
honey was given internally and  Neeradimuthu pasai-QS for external use were given to 
the patients. 
· Diet restrictions were strictly imposed during the treatment period.  Every 8th day the 
patients were assessed for clinical improvement and adverse effects.  On the 30th day 
photographs were repeated.  The improvement was assessed.  
· During the course of treatment there were no adverse effects or unwanted drug reactions 
such as nausea, abdominal discomfort. Hence the trial drugs were considered as safte. 
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CONCLUSION 
The treatment was given for Padar thamarai on the basis of principles of Siddha 
system deranged Thri Thodams were corrected by the trials medicine given to the Padar 
thamarai. 
The present clinical study reveals that the trial drug showed Grade - 2 (Reduction of 
hyper pigmentation) improvement in 71 % of the cases, Grade 3 (Reduction of size and 
oozing) improvement in 24% of the cases, Grade 4 (Reduction of itching) improvement in 
5% cases. 
There was no adverse effects were reported during the study. Hence the trials drugs 
are considered as safe. The preparation of Internal and External Medicine were simple also. It 
is concluded that the trial drugs were therapeutically effective against Padar Thamarai. 
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NATIONAL INSTITUTE OF SIDDHA 
ACUTE TOXICITY STUDY OF PARANGICHAKKAI CHOORANAM 
[WHO guidelines, 1993] 
Principle: 
   Acute toxicity was carried out in Swiss albino mice with a single exposure of 10 times of 
the recommended therapeutic dose of test compound the study duration will be 14 days. 
Animal species  : Swiss albino mice 
Age / Weight / Size  :  6 weeks.  Mice-20-25 gms. 
Gender   :   Both male and female 
Number of Animals   : Mice: 10 
Acclimatization Period : 7 Days 
Clinical dose   :          162 mg\day 
 
S.No Group No of mice 
1 Vehicle control (saline) 10  (5 male, 5 female) 
 
2 
Toxic dose 
10X therapeutic dose 
 (1620mg) 
10  (5 male, 5 female) 
 
Test Animals  
      Test animals were obtained from the animal laboratory of the King institute, Chennai and 
stocked at National institute of siddha, Chennai. All the animals were kept under standard 
environmental condition (27+ or – 2 degree c).The animals had free access to water and standard 
pellet diet (Sai Durga foods pvt.ltd, Bangalore).The principles of laboratory animal care were 
followed and the  Institutional ethical committee approved the use of animals and the study 
design. (1248/ac/09/CPCSEA/February/ 2012) 
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 Route of administration: 
 Oral route was selected, because it is the normal route of clinical administration. 
Test substance and vehicle 
       The Parangichakkai Chooranam is Brown in colour.  The test substance is insoluble in 
water, in order to obtain and ensure the uniformity in drug distribution the drug is dissolved by 
aqueous Tween 80 solution (10%).  
Administration of doses 
           Parangichakkai chooranam was suspended in aqueous Tween 80 solution (10%), with 
uniform mixing and it was administered to the groups in a single oral dose .The control groups 
were received equal volume of the vehicle. The animals were weighed before giving the drug. 
The dose level was calculated according to body weight, and surface area. Since the clinical dose 
was 162mg\day it was converted to animal dose (1620mg) and then administered. The principle 
of laboratory animal care was followed. 
Observations 
 Observations were made and recorded systematically and continuously observed as per 
the guideline after substance administration. The animals were monitored for behavioural 
parameters like 
1. Awareness 
- Alertness 
- Visual placing 
- Stereotype 
- Passivity 
2. Mood 
-  Grooming 
-  Restlessness 
-  Irritability 
-  Fearfulness 
3. Motor activity 
- Spontaneous activity 
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- Reactivity 
- Touch response 
- Pain response.  
Animals were observed for body weight and mortality for 14 days. If animals died during 
the period of study, the animals were sacrificed.  At the end of the 14th day all animals were 
sacrificed and necropsy was done. 
Body Weight 
 Individual weight of animals was determined before the test substance was administered 
and daily for 14 days. Weight changes were calculated and recorded. At the end of the test, 
surving animals were weighed and sacrificed. 
Results:   
Parangaichakkai chooranam at the dose 1620mg/animal did not exhibit any mortality in 
mice. No behavior changes were noted for the first 4 hours and for the next 24 hours and 
throughout the study period of 14 days. No weight reduction was noted before and after the acute 
study duration. Reflexes were found to be normal before and after the study. All other 
observations were found to be normal before and after the study. In Necropsy, the organs of the 
animal such as, Liver, Heart, Lungs, Pancreas, Spleen, Stomach, Intestine, Kidney, Urinary 
bladder, Uterus all appeared normal. 
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BIO -CHEMICAL ANALYSIS OF PARANGICHAKKAI CHOORANAM 
ANALYSED AT NATIONAL INSTITUTE OF SIDDHA 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Physical Appearance of sample Light brown  in olour  
2. Solubility: 
a. A little (500mg) of the sample is 
shaken well with distilled water. 
b. A little (500mg) of the sample is 
shaken well with con. HCl/Con. H2So4 
Sparingly soluble 
 
 
Presence of Silicate 
3. Action of Heat: 
   A small amount(500mg) of the 
sample is taken in a dry test tube and 
heated gently at first and then strong. 
 
White fumes  evolved 
 
Presence of Carbonate 
 
4. Flame Test: 
  A small amount (500mg) of the 
sample is made into a paste with con. 
HCl in a watch glass and introduced 
into non-luminous part of the Bunsen 
flame. 
No Bluish green lame 
appeared. 
Absence of Copper 
5. Ash Test:s A filter paper is soaked 
into a mixture of sample and dil. 
cobalt nitrate solution and introduced 
into the Bunsen flame and ignited 
No Yellow colour 
flame 
Absence  of sodium 
 
Preparation of Extract:  5gm of Parangichakkai chooranam is weighed accurately and 
placed in a 250ml clean beaker and added with 50ml of distilled water. Then it is boiled well 
for about 10 minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up 
to 100ml with distilled water. 
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S.No EXPERIMENT OBSERVATION INFERENCE 
 I. Test For Acid Radicals   
1. Test For Sulphate: 
a.2ml of the above prepared extract is taken in a 
test tube to this added 2ml of 4% dil ammonium 
oxalate solution 
No Cloudy 
appearance 
present 
Absent of 
Sulphate 
2. Test For Chloride: 
2ml of the above prepared extracts is added with 
2ml of dil-HCl is added until the effervescence 
ceases off.. 
No cloudy 
appearance 
present 
Absent of 
Chloride 
3. Test For Phosphate: 
2ml of the extract is treated with 2ml of 
dil.ammoniummolybdate solution and 2ml of 
con.HNo3 
Cloudy yellow 
appearance 
present 
Presence of 
Phosphate 
4.  Test For Carbonate: 
2ml of the extract is treated with 2mldil. 
magnesium sulphate solution 
No Cloudy 
appearance 
present 
Absent 
of Carbonate 
C Test For Nitrate: 
1gm of the substance is heated with copper turning 
and concentrated H2So4 and viewed the test tube 
vertically down. 
No Brown gas 
is evolved 
Absence  
of Nitrate 
6. Test For Sulphide: 
1gm of the substance is treated with 2ml of con. 
HCL 
No rotten Egg 
Smelling gas 
evolved 
Absence 
of Sulphide 
7. Test For Fluoride & Oxalate: 
2ml of extract is added with 2ml of dil. Acetic acid 
and 2ml dil.calcium chloride solution and heated. 
 No Cloudy         
appearance 
Absence of 
fluoride and 
oxalate 
 
8. 
Test For Nitrite: 
3drops of the extract is placed on a filter paper, on 
that-2 drops of dil.acetic acid and 2 drops of 
dil.Benzidine solution is placed. 
Shows 
Characteristic 
changes 
Presence of 
Nitrite 
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9. Test For Borate: 
2 Pinches(50mg) of the substance is made into 
paste by using dil.sulphuric acid and alcohol 
(95%) and introduced into the blue flame. 
Bluish green 
colour flame 
not appeared 
   Absence  
of borate 
II. Test For Basic Radicals 
1. Test For Lead: 
2ml of the extract is added with 2ml of 
dil.potassium iodine solution. 
NoYellow 
Precipitate is 
obtained. 
Absence of 
lead 
2. Test For Copper: 
a. One pinch(50mg) of substance is made into 
paste with con. HClin a watch glass and 
introduced into the non-luminuous part of the 
flame. 
No Blue colour 
flame 
No Blue colour 
precipitate 
formed. 
  Absence  
of copper 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium hydroxide is 
added in 5 drops to excess. 
No 
characteristic 
changes 
Absence 
of aluminium 
4. Test For Iron: 
a.To the 2ml of extract add 2ml of dil.ammonium 
solution 
b.To the 2ml of extract 2ml  thiocyanate solution 
and 2ml  of con HNo3 is added 
 
Red colour 
appeared 
 
Presence of 
Iron 
5. Test For Zinc:  
To 2ml of the extract dil.sodium hydroxide 
solution is added in 5 drops to excess and 
dil.ammonium chloride is added.  
 
White 
precipitate is   
not formed 
  Absence of 
Zinc 
6. Test For Calcium:  
2ml of the extract is added with 2ml of 4% 
dil.ammonium oxalate solution  
No Cloudy 
appearance and 
white 
precipitate is 
obtained 
Absence of 
calcium 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide solution is 
added in drops toexcess. 
No white 
precipitate is  
obtained 
Absence  
of Magnesium 
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8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's reagent and 
excess of dil.sodium hydroxide solution are added. 
No Brown 
colour 
appeared 
Absence  
 of ammonium 
9. Test For Potassium: 
A pinch(25mg) of substance is treated of with 2ml 
of dil.sodium nitrite solution and then treated with 
2ml of dil.cobalt nitrate in 30% dil.glacial acetic 
acid. 
 
 Yellowish 
precipitate is 
obtained. 
 
Presence of 
Potassium 
10. Test For Sodium: 
    2 pinches(50mg) of the substance is made into 
paste by using HCl and introduced into the blue 
flame of Bunsen burner. 
 
No Yellow 
colour flame 
appeared 
 
Absence   
of Sodium 
11. Test For Mercury:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution.  
yellow 
precipitate is 
obtained 
Absence of 
Mercury 
12. Test For Arsenic:  
   2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution. 
No brownish 
red precipitate 
is obtained 
Absence  
of Arsenic 
III. Miscellaneous 
1.
  
Test For Starch: 
2ml of extract is treated with weak dil.Iodine 
solution  
No Blue colour 
developed 
Absence 
of starch 
2.
  
Test For Reducing Sugar: 
    5ml of Benedict's qualitative solution is taken 
in a test tube and allowed to boil for 2 minutes 
and added 8 to 10 drops of the extract and again 
boil it for 2 minutes. The colour changes are 
noted. 
Brick red 
colour is 
developed 
Presence of  
reducing sugar 
3.
  
Test For The Alkaloids: 
a) 2ml of the extract is treated with 2ml of 
dil.potassiumlodide solution. 
b)  2ml of the extract is treated with 2ml of 
 
.Red colour 
developed 
Yellow colour 
 
- 
 
Presence 
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dil.picric acid. 
c)  2ml of the extract is treated with 2ml of 
dil.phosphotungstic acid. 
developed 
White 
precipitate 
developed 
of Alkaloid 
4.
  
Test For Tannic Acid:  
2ml of extract is treated with 2ml of dil.ferric 
chloride solution  
 No black 
precipitate is 
obtained 
Absence 
of Tannic acid 
5.
  
Test For Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate 
is not 
decolourised 
 Absence  
of unsaturated 
compound  
6.
  
Test For Amino Acid: 
2 drops of the extract is placed on a filter paper 
and dried well. 20ml of  Biurette reagent is added. 
 
No Violet 
colour 
developed 
 
Absence   
of amino acids 
7. Test For Type Of Compound: 
2ml of the extract is treated with 2 ml of dil.ferric 
chloride solution.  
No green 
colour 
developed 
No red colour 
developed 
 
 
No violet 
colour 
developed 
No  blue 
colour 
developed. 
Absence of 
oxy 
quinolepinephr
ine and pyro 
catechol. 
Anti pyrine, 
Aliphatic 
amino acids 
and meconic 
acid are absent  
Apomorphine 
salicylate and 
Resorcinol are 
absent 
morphine, 
Phenol cresol 
and 
hydrouinonear
e absent 
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Preliminary Qualitative Phyto chemical tests procedure and interpretation of results 
S.NO CONSITUENTS INFERENCE 
1.  Silicate Present 
2.  Carbonate Present 
3.  Nitrite Present 
4.  Pottassium Present 
5.  Iron Present 
6.  Alkaloids Present 
7.  Phosphate Present 
8.  Reducing sugar Present 
9.  Sulphate Absent 
10.  Chloride Absent 
11.  Nitrate Absent 
12.  Oxalate Absent 
13.  Fluoride Absent 
14.  Borate Absent 
15.  Lead Absent 
16.  Aluminium Absent 
17.  Zinc Absent 
18.  Calcium Absent 
19.  Magnesium Absent 
20.  Ammonium Absent 
21.  Sodium Absent 
22.  Mercury Absent 
23.  Arsenic Absent 
24. Starch Absent 
25. Sulphide Absent 
26. Tannic Acid Absent 
27. Unsaturated compound Absent 
28. Amino Acid Absent 
29. Type of compounds Absent 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM l - SCREENING AND SELECTION PROFORMA 
1.OP NO:  ....................................................... 
2. NAME:  ………………………………………….   
3. AGE:      ………       4.GENDER: …………....... 
5. OCCUPATION: ………………………………..      6.INCOME:   ………………… 
7. ADDRESS:    ……………………………………     
…………………………………… 
…………………………………… 
8. CONTACT NO:    ……………………………………              
INCLUSION CRITERIA : 
o Age:20-60 
o Sex: Both Male and Female.  
o Typical distribution of the lesions presenting on  following parts of the body such 
as face, axilla, body, inguinal regions and nails except head.  
o Well defined raised margin with clearance in the central area of the lesion.  
o Marked itching.  
o Willing to sign the informed consent stating that he/she will consciously stick to 
the treatment during 30 days. 
o Willing to give blood and urine samples for laboratory investigations  
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EXCLUSION CRITERIA 
o  Lesions with secondary infections  
o Deep type of Tinea barbae.  
o Sexually transmitted disease 
o Diabetes  
o Hypertension  
o Leprosy 
o Any other systemic diseases  
ADMITTED TO TRIAL  
   
   YES   NO  
   
 
  If yes, serial No: 
 
 
Date:        
Station: 
Signature of the Investigator: 
 
 
Signature of the Lecturer:                                                           Signature of the HOD  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM lI - HISTORY PROFORMA ON ENROLLMENT 
1. SERIAL NO OF THE CASE: …………………   
2.OP / IP NO: ......................................    
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................                           
6. COMPLAINTS & DURATION:                                                                                                                                                                                       
  
 
 
 
7. HABITS: 
                        SMOKING  
YES / NO                  If yes, specify duration    ------- yrs------months 
  
TOBACCO  CHEWING 
YES/ NO                   If yes, specify duration    ------- yrs-------months 
  
ALCOHOLISM 
YES / NO                 If yes, specify duration    -------- yrs-------months 
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8.ALLERGY TO DRUG: 
 
 
 
9. FAMILY HISTORY: 
 Whether this problem runs in family? 
                                         1. Yes                               2.No         
                                     If yes, mention the relationship of affected person(s) 
                                               1._________________ 
                                               2._________________ 
                                               3._________________ 
10.DIETARY HABIT:     
                                1.Vegetarian              
                                2.Non-vegetarian 
11. MENSTRUAL HISTORY: 
 
 
 
Date:        
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                           Signature of the HOD  
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM III - CLINICAL ASSESSMENT ON ENROLLMENT 
1.OP NO:  ------------ 2.IP NO: ---------------    3.BED NO: ------   4.SI NO:   ------ 
5. NAME: ------------------------------        6. AGE:   ---------              7.GENDER:  ------ 
8. DATE OF INITIAL ASSESSMENT:     ----------------------             
9. GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cm]                        :                        
3. Body Temperature [oF]      :   
4. Blood Pressure (mmHg)  :      
5. Pulse Rate /min.        : 
6. Heart Rate / min.         : 
7. Respiratory Rate /min.  :   
                                                                                   Yes            No   
8. Pallor  :   
9. Jaundice  :   
10. Clubbing  : 
11. Cyanosis  : 
12. Pedal Oedema  : 
13. Lymphadenopathy           :                                        
14. Jugular venous pulsation  :   
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10. SYSTEMIC EXAMINATION: 
    Normal          Abnormal 
1. Cardio-vascular system 
2. Respiratory system           
3. Gastro- intestinal system   
4. Central nervous system 
5.  Uro-genital system     
6.  Endocrine system                                                    
11. SIDDHA SYSTEM OF EXAMINATION  
1. THEGI (TYPE OF BODY CONSTITUTION): 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range)  
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Arid regions) 
3. KAALAM: 
1. Kaar kaalam 
2. Koothir kaalam 
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3. Munpani kaalam 
4. Pinpani kaalam 
5. Ilavenil kaalam 
6. Muthuvenil kaalam 
4. GUNAM: 
1. Sathuvam 
2. Rasatham 
3. Thamasam 
5. PORIPULANGAL (SENSORY ORGANS):                
 
6. KANMENDRIYAM (MOTOR ORGANS) 
 
 0th day 8th day 16th day 24th day 31st day 
Kai (upper 
limb) 
     
Kaal (lower 
limbs ) 
     
 
 0th day 8th day 16th day 24th day 31st day 
Mei 
(Skin) 
     
Vai 
(Tongue) 
     
Kann 
(Eye) 
     
Mooku 
(Nose) 
     
Sevi 
(Ear) 
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Vai   
(Speech) 
     
Eruvai 
(excretory 
organs) 
     
Karuvai  
(reproductive 
organs) 
     
 
7. KOSANGAL (SHEATH): 
       Before treatment After treatment 
Annamaya 
Kosam   
Pranamaya 
Kosam   
Manomaya 
Kosam   
Vignanamaya 
Kosam   
Ananthamaya 
Kosam   
 
8. UYIR THATHUKKAL (THREE HUMOURS): 
8a.VALI:        
 0th day 8th day 16th day 24th day 31st  day 
Praanan  (Uyirkkaal)          
 
 
    
Abaanan(Keezhnokkunkaal)      
Viyaanan(Paravukaal)      
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B) AZHAL 
 Before treatment After treatment 
Analakam(aakkanal)   
Ranjakam(Vanna eri)    
Saathakam (Atralangi)   
Prasakam (Ullolithee)   
Aalosakam(Nokkazhal)   
 
C) IYAM 
 Before treatment After treatment 
Avalambagam(Aliaiyam)   
Kilethagam(Neerppeiyam)   
Pothagam(Suvaikaaniyam)   
Tharpagam(Niraiviyam)   
Santhigam(Ontriiyam)   
Udhaanan(Melnokkunkaal)      
Samaanan(Nadukkaal)      
Naagan      
Koorman      
Kirukaran      
Devathathan      
Dhananjeyan 
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9. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
         Before treatment After treatment 
Saaram   
Senneer   
Oon   
Kozhuppu   
Enbu 
 
  
                    Moolai   
      Sukkilam/ Suronitham    
 
10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 I. NAADI: [PULSE PERCEPTION] 
  
II. SPARISAM: 
0th day 8th day 16th day 24th day 31st  day 
Warmth/ 
Cold/Normal 
 
Warmth/ 
Cold/Normal 
 
Warmth/ 
Cold/Normal 
 
Warmth/ 
Cold/Normal 
 
Warmth/ 
Cold/Normal 
 
Days Naadi nadai 
0th day  
8th day  
16th day  
24th day  
31st  day  
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III. NAA: [TONGUE] 
 Before treatment After treatment 
Colour   
Taste   
Coating   
Fissure   
Dryness   
Glossitis   
Others   
IV.NIRAM: [COMPLEXION]   
     1. Vadham         
     2. Pitham 
     3. Kabam  
V.MOZHI: [VOICE] 
      1. High Pitched 
      2. Low Pitched 
      3. Medium Pitched 
VI.VIZHI: [EYES]  
0th day 8th day 16th day 24th day 31st day 
     
VII. MALAM: [BOWEL HABITS / STOOLS] 
 Before treatment After treatment 
Colour   
Consistency   
Stool  bulk   
119 
 
Constipation (Irugal)   
Diarrhoea (Ilagal)   
Others   
                                              
                                                                                                                                          
VIII. URINE EXAMINATION 
   
NEIKKURI 0th day 8th day 16th day 24th day 31st day 
Serpentine Pattern      
Annular/Ringed 
Pattern      
Pearl beaded 
Pattern 
     
Other Pattern      
 
 
NEERKKURI 0th day 8th day 16th day 24th day 31st  day 
Niram 
[Colour] 
     
Edai 
[Sp.gra] 
     
Manam[Odour] 
 
     
Nurai[Froth]      
Enjal 
[Deposits] 
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  11. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS)  
         Before treatment After treatment 
Saaram   
Senneer   
Oon   
Kozhuppu   
Enbu 
 
  
                    Moolai   
      Sukkilam/ Suronitham    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM lV -     CLINICAL ASSESSMENT DURING  AND AFTER TRIAL 
1. OP/ IP NO: …………      2. SL. NO: ……… 3.NAME: …………………………………..       
4. AGE: ………          5. GENDER: …...  6. DATE OF RECRUITMENT: ………………… 
 0th day 8th day 16th day 24th day 31st day 
        Site 
Colour      
Size      
Shape      
Border      
Itching      
Erythema      
Vesicle      
Papule      
Date:          
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                              Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
                                       FORM V- LABORATORY INVESTIGATIONS 
Blood Investigations Normal 
Values 
Before trmt 
 
After trmt 
 
Hb( gm/dl) 
M:12-15 
W:11.5-14 
  
T.WBC (cells/Cu.mm) 4000-11000   
DIFFERENTIAL 
COUNT (%) 
Polymorphs 40-75   
Lymphocytes 20-40   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
T.RBC(million cells/Cu.mm) 
 
M:4.0-5.5 
W:3.5-4.5 
 
 
 
 
 
 
 
ESR(mm/hour) ½ hr. M:6-12 
W:7-18 
  
  1 hr.   
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Blood Investigations Normal Values 
Before trmt  
 
After trmt 
Blood 
glucose 
(mg/dl) 
Fasting    70-110   
PP    80-140   
Random    80-120   
RFT 
(mg/dl) 
Blood urea    16-50   
Serum creatinine    0.6-1.2   
LFT 
(mg/dl) 
Total bilirubin    0.2-1.2   
Direct bilirubin    0.1-1.2   
Indirect bilirubin    0.2-0.7   
SGOT     0-40   
SGPT     0-35   
Alkaline 
phosphatase 
   80-290   
Urine investigation Before trmt 
 
After trmt 
Albumin   
Fasting sugar   
PP sugar   
Deposits   
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
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 ேதசிய சி த ம   வ நி வன , ெச ைன  -600 047 
      அேயா திதாச ப  த  ம   வமைன 
பட  தாமைர (  ட க   ட ) ேநா  கான சி த ம   கள  
(பர கி ச ைக ரண , ந ர     பைச) ப க     திறைன  க டறி   
ம   வ ஆ வ கான தகவ  ப வ  
தகவ  ப வ  
 த ைம ஆரா  சியாள  ெபய  :   Dr. மா. சத  மா  
நி வன தி  ெபய    :  ேதசிய சி த ம   வ நி வன  
       தா பர  சானேடா ய  
       ெச ைன- 47 
ேதசிய சி த ம   வ தி  ப ட ேம  ப    பய   வ   நா  
பட  தாமைர எ    ேதாைல பாதி    ேநாய  ம   வ 
ஆரா  சிய  ஈ ப   ேள . 
பட  தாமைர (  ட க    ட )  எ    ேநாயான  சி த 
ம   வ தி  18 வைக   ட க    ேதாலிைன  பாதி    
ேநா கள  ஒ  , இ   , ெதாைட இ   ,  தலிய இட கள  
உ டாகி நைம ச  க   ெசா ய  ெச   , கா த  உ டா  , இ  
ெதா   ேநா கள  ஒ  . 
 ­ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä §¸ûÅ¢¸¨Ç §¸ð¸×õ, §¾¨ÅÂ¡É 
¬öÅ¸  ÀÃ¢§º¡¾¨ÉìÌò ¾í¸¨Ç ¯ðÀÎò¾×õ ¯û§Çý. 
­ó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ Àðºò¾¢ø உ  
ம  தாக பர கி ச ைக   ரண  5 கிரா  ேதன  2 ேவைள (காைல 
மாைல) உண     ப  30 நா க    உ ெகா ள ேவ   , ெவள  
ம  தாக ந ர      பைசய ைன  ள த ந   கல     ேநா  ள 
இட கள  ெவள ேய தடவ ேவ   . ெவள  ேநாயாள க  7 
நா க    ஒ   ைற ம   வமைன   வரேவ   . ¯û 
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§¿¡Â¡Ç¢Â¡¸ ¾í¸ Å¢ÕôÀõ ¦¾Ã¢Å¢ìÌõ Àðºò¾¢ø §¿¡öìÌò ¾Ìó¾ §Â¡¸ô 
ÀÂ¢üº¢ «Ç¢ì¸ôÀÎõ.  ­ó¾ ÁÕóÐ º¢ÈôÀ¡¸ பட  தாமைர   §¿¡öì¸¡¸ 
«í¸£¸Ã¢ì¸ôÀð¼ º¢ò¾ ÁÕòÐÅ áÄ¢ø ÜÈôÀðÎûÇÐ. 
­ó¾ ¬Ã¡öîº¢Â¢ø ¾í¸¨Ç «ÛÁ¾¢ò¾ À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀõ 
­ø¨Ä¦ÂÉ¢ø ±ô§À¡Ð §ÅñÎÁ¡É¡Öõ ¬Ã¡öîº¢Â¢ø þÕóÐ Å¢Ä¸¢ì 
¦¸¡ûÇ ¯Ã¢¨Á ¯ûÇÐ. 
­ó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ ÁüÈ Å¢ÀÃí¸ÙìÌõ 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕòÐÅ÷: Dr. மா. சத   மா   (ப ட ேம  
ப  பாள  சிற   ம   வ ப  )அ க  . ைக ேபசி எ : 9962403457. 
 §ÁÖõ  ­ó¾ ¬Ã¡öîº¢ìÌ ¾ì¸ «ÛÁ¾¢ º¡ýÚ (IEC) 
¦ÀÈôÀðÎûÇÐ. 
þó¾ ÁÕóÐ ÓüÈ¢Öõ À¡Ð¸¡ôÀ¡É ãÄ¢¨¸¸¨Çì ¦¸¡ñÎ 
¾Â¡Ã¢ì¸ôÀðÎûÇÐ. Àì¸ Å¢¨Ç×¸¨Ç ²üÀÎò¾¡Ð. 
§ÁÖõ ¯½× Ó¨ÈÂ¢ø ÁÕòÐÅÃ¡ø ÜÈôÀÎõ Àò¾¢Âõ  ¸¡ìÌÁ¡Ú 
«È¢×Úò¾ ÀÎ¸¢ÈÐ. 
­Ð ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ 
±É ¯Ú¾¢«Ç¢ì¸¢§Èý. 
­¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ò ¦¾¡¨¸Ôõ ÅÆí¸ô À¼ Á¡ð¼¡Ð. 
­ó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ Àðºò¾¢ø 
§¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ. 
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ேதசிய சி த ம   வ நி வன , ெச ைன- 47 
அேயா திதாச  ப  த  ம   வமைன 
பட  தாமைர (  ட க  ட  ) ேநா  கான சி த ம   கள  
(பர கி ச ைக ரண , ந ர     பைச) ப க     திறைன  க டறி   
ம   வ ஆ வ கான ஒ  த  ப வ  
 
                ¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
    ¿¡ý þó¾ ¬ö× ÌÈ¢ò¾ «¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌ ÒÃ¢Ôõ 
Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É ¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 §¾¾¢ :                                                     ¨¸¦Â¡ôÀõ: 
 þ¼õ:                                                      ¦ÀÂ÷     : 
 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ  þó¾ ÁÕòÐÅ ¬öÅ¢ý ¸¡Ã½ò¨¾Ôõ, ÁÕó¾¢ý ¾ý¨Á ÁüÚõ 
ÁÕòÐÅ ÅÆ¢Ó¨È ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ ±ÉÐ ¯¼ø þÂì¸ò¨¾ò  ¸ñ¸¡½¢ì¸×õ, 
«¾¨É À¡Ð¸¡ì¸×õ ÀÂýÀÎõ ÁÕòÐÅ ¬ö×ìÜ¼ ÀÃ¢§º¡¾¨É¸û ÀüÈ¢   ¾¢Õô¾¢ 
«Ç¢ìÌõ Å¨¸Â¢ø ¬ö× ÁÕòÐÅÃ¡ø Å¢Çì¸¢ì ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ¸¡Ã½õ ±Ð×õ ÜÈ¡Áø, ±ô¦À¡ØÐ 
§ÅñÎÁ¡É¡Öõ þó¾ ¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ ¦¸¡ûÙõ ¯Ã¢¨Á¨Â 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âò  
¦¸¡ñÎ பட  தாமைர (   ட க   ட  ) ேநா  கான சி த ம   கள  
(பர கி ச ைக  ரண  (¯û ÁÕóÐ) ÁüÚõ ந ர     பைச (¦ÅÇ¢ ÁÕóÐ) 
ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É ¯ðÀÎò¾ 
´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 §¾¾¢:                                                        ¨¸¦Â¡ôÀõ: 
þ¼õ:                                                        ¦ÀÂ÷     : 
 
 §¾¾¢:                                                        º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
 þ¼õ:                                                        ¦ÀÂ÷                :                                             
¯È×Ó¨È         : 
Å¢Ã¢×¨ÃÂ¡Ç÷ ¨¸¦Â¡ôÀõ:                       Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ:  
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                           NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASS PANDITHAR HOSPITAL 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
        FORM VI .A.– (INFORMATION SHEET)  
Name of the Principal Investigator:  Dr.M.SATHISHKUMAR 
Part – A Information Sheet 
Padarthamarai is one among the 18 types of kuttam.It principally affects the skin 
especially face, axilla, body, inguinal region and nails causing a severe itching and 
burning sensation. It is a highly contagious disease . This condition is being treated in 
NIS with many Siddha formulations. As a part of M.D(S) research programme and 
developing new efficacious medicine, I proposed to study the efficacy of 
PARANGICHAKKAI CHOORNAM (Internal), NEERADIMUTHU PASAI (External) 
formulations for treating the condition. This formulation has been mentioned in Siddha 
literature and empirical evidence with contemporary tools is required for documentation.  
Trial medicines  will be given  free of cost. The duration of treatment period is 30 
days.The patient`s have to visit the OPD of NIS hospital once in every 7 days and collect 
the drugs for 7 days. The diagnostic tests will be carried out  free of cost. I will assess the 
effect of treatment after completion of 30 days of treatment using clinical and laboratory 
parameters. 
In this regard, I need to ask few questions. I will maintain confidentiality of the 
patient`s comments and data obtained from him / her. There will be no risk of disclosing 
your identity and no physical, psychological or professional risk is involved by taking 
part in this study.  
Taking part in this study is voluntary. No compensation will be paid to the patient 
for taking part in this study. The patient can choose not to answer any specific question. 
There is no specific benefit for the patient`s if they take part of in this study, but they will 
be under our clinical monitoring and specific attention will be given. Taking part in this 
study may be of benefit to the community, as it may help us to develop medicine for 
Padarthamarai. During the treatment if any adverse symptoms like passing loose stools, 
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irritation in the stomach, indigestion occur, shall be reported to NIS and treatment will be 
given in NIS hospital for relief. The patient`s will be allowed to withdraw from the study 
at any stage of treatment period, if they are not interested to continue and  they will 
receive our usual treatment without any condition. 
The information  collected in the study, will be kept confidential. I may ask the 
patient`s some  questions through a questionnaire. We will not write the patient`s name 
on different forms which  are sent to different investigating / analysis sections and we will 
use a code instead given by principal investigator. Only the principal investigator will 
know the key to this code which will be kept in safe custody. If a patient agrees to be a 
participant in this study, he / she will be screened as per the study protocol. 
If they wish to find out more about this study before taking part, they can ask  or contact 
Dr.M.SATHISHKUMAR, P.G scholar cum principal investigator of this study, attached 
to the National Institute of Siddha, Chennai (Mobile No. 9962403457). You can also 
contact the chairman / Member Secretary of ethics committee, national Institute of 
Siddha, Chennai-600047, Tel No.: 914422411611, for rights and Participation in the 
study.     
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASS PANDITHAR HOSPITAL 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM VI.B. - CERTIFICATE OF CONSENT 
 
“I have read the foregoing information, or it has been read to me. I have had the 
opportunity to  ask questions about it and any questions I have asked have been answered to 
my satisfaction.  
             I   consent voluntarily to participate as a participant in this study and understand that 
I have the   right to withdraw from the study at any time without in any way it affecting my 
further medical  care”. 
 
"I have received a copy of the information sheet/consent form". 
Date:  
Signature of the participant 
 
In case of illiterate participant 
 
 “I have witnessed the accurate reading of the consent form to the potential 
participant, and the  individual has had the opportunity to ask questions. I confirm that the 
individual has given consent freely.”                                                   
 
 
 
Date: 
 Signature of a witness: 
          
Left thumb impression of the                                              
Participant      
                                                                                                                                                                                                                                     
(Selected by the participant bearing no connection with the survey team) 
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NATIONAL INSTITUTE OF SIDDHA, CHENNAI – 47 
AYOTHIDASS PANDITHAR HOSPITAL 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM IV.C.  - DIETARY ADVICE FORM 
§º÷ì¸ì ÜÊÂ ¯½×¸û (Diet to be included): 
¸¡ö¸û (Vegetables): 
      ÓÕí¨¸ôÀ¢ïÍ (Unripe drumstick) 
«Å¨ÃôÀ¢ïÍ (Unripe Dolichos bean) 
À¢Ãñ¨¼ (Cissus quadrangularis,Linn) 
¸¡Ãð ( Carrot, Doucos carota) 
À£ðåð ( Beet Root, Beta vulgaris) 
¸£¨Ã¸û (Greens): 
¸Ã¢º¡¨Ä (trailing eclipta [Eclipta prostrate] ) 
¦À¡ýÉ¡í¸¡½¢ (Sessile plant [Alternanthera sessilis] ) 
Á½ò¾ì¸¡Ç¢ (Black night shade[Solanum nigrum] )         
ÓÕí¨¸ì¸£¨Ã (Leaves of Drumstick [Moringa oleifera] ) 
Àº¨Äì¸£¨Ã (Portuiaca quadrifida,Linn) 
º¢Ú¸£¨Ã (Amaranthus tricolor,Linn)                 
¸È¢§ÅôÀ¢¨Ä (Curry leaves [Murraya koenigii] )   
      ¦¸¡ò¾ÁøÄ¢ (Coriander leaves [Coriandrum sativum, Linn]) 
      Ò¾¢É¡(Mentha piperita, Linn) 
ÀÆí¸û (Fruits): 
Á¡Ð¨Ç (Pomegranate) 
¬ôÀ¢û (Apple) 
Å¡¨Æ (Banana) 
§ÀÃ£î¨º (Dates) 
«ò¾¢ (Fig)               
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¾¢Ã¡ð¨º (Grapes) 
¦¸¡öÂ¡ (Guava [Psidium guajava.Linn] )                
¿¡Åø (Jambul [Syzygium cumini] ) 
¯Ä÷ ¾¢Ã¡ð¨º (Dry Grapes) 
 
¾¡É¢Âí¸û (Seeds): 
Ó¨Ç ¸ðÊÂ ÀÂ¢÷ Å¨¸¸û(Sprouted grains)  
§º¡Â¡À£ýŠ(Soya beans) 
 ¦Åó¾Âõ(Fenugreek seeds [Trigonella foenum graecum] ) 
 
«¨ºÅõ (Non-vegetarian diet): 
¦ÅûÇ¡ðÎì¸È¢ ®Ãø (Goat`s meat, liver)  
±ÖõÒÁˆ¨ƒ(Bone marrow) 
 
ÁüÈ¨Å (Others): 
À¨É ¦ÅøÄõ(Palm jaggery) 
À¡ø (Milk)   
 
¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û (Diet to be avoided)       
§¸¡Æ¢ì¸È¢, Á£ý, ¿ñÎ, ¸ÕÅ¡Î (Hen meat, Fish, Crab, Dryfish) 
§Å÷ì¸¼¨Ä ( Ground nut [Arachis hypogaea] ) 
±ûÙ (Sesame seeds [Sesamum indicum] ) 
ÀôÀ¡Ç¢ (Pappaya [Carica papaya] ) 
«ýÉ¡º¢ (Pine Apple [Ananas comosus] ) 
¿ø¦Äñ¦½ö (Gingelly oil) 
ÒÇ¢ôÒ ¦À¡Õû¸û (Products of sour taste) 
±ÖÁ¢î¨º (Lemon [Citrus limon] ) 
¾ì¸¡Ç¢ ( Tomato, Cape gooseberry [Physalis minima] ) 
ÒÇ¢ôÒ ¾Â¢÷, §Á¡÷ (Sour curd,butter-milk) 
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°Ú¸¡ö (Pickles) 
¦Àñ§À¡¸õ(Sexual intercourse) 
¦ÅüÈ¢¨Ä,À¡ìÌ (Betle leaves, Areca-nut) 
Ò¨¸Â¢¨Ä (Tobacco) 
ÁÐ «ÕóÐ¾ø (Alcohol)  
ÁÕòÐÅ «È¢×¨Ã (Medical advice):  
¯¼Ä¢ø §¿¡Â¡ø À¡¾¢ì¸ôÀð¼ þ¼í¸Ç¢ø ¦¸¡Îì¸ôÀð¼À¨º¨Â ¾¼Å¢ 
þÇ ¦Åó¿£Ã¢ø ¸ØÅ¢ Íò¾Á¡É ¦ÅûÇ¡¨¼¸¨Ç «½¢óÐ àö¨ÁÂ¡¸ þÕì¸ 
§ÅñÎõ.  
Affected body parts should be treated with the given paste, and it should 
be cleaned with luke warm water.         
      Clean and neat white dresses should be worn 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
FORM VII - WITHDRAWAL FORM 
1. SERIAL NO : …………………   
2.OP / IP NO: ......................................    
3. NAME: ……………………………   4.AGE: ………     5.GENDER: .................                          
6. DATE OF TRIAL COMMENCEMENT: ………………... 
7. DATE OF WITHDRAWAL FROM TRIAL: …………….. 
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:              Yes/ No 
Irregular treatment:                          Yes/ No 
Shift of locality:                                    Yes/No 
Increase in severity of symptoms:    Yes/No 
Development of severe adverse drug reactions:  Yes/No 
 
Date:          
Station: 
Signature of the Investigator: 
 
Signature of the Lecturer:                                                              Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam)                                                                                
FORM VIII  - DRUG COMPLIANCE FORM 
SERIAL NO: 
PATIENT`S  NAME:  
DRUG NAME:PARANGICHAKKAI  CHOORNAM  
FOR OPD  
On 1st     day-Date:  Drugs issued:  (Gms) Drugs returned:   (Gms) 
On 8th   day-Date:   Drugs issued:  (Gms) Drugs returned:   (Gms) 
On 16th day-Date:              Drugs issued:  (Gms) Drugs returned:   (Gms) 
On 24th day-Date:           Drugs issued:  (Gms) Drugs returned:    Gms) 
FOR IPD 
Day Date Morning 
 
Evening 
 
Day Date Morning 
 
Evening 
 
Day 1    Day 2    
Day 3    Day 4    
Day 5    Day 6    
Day 7    Day 8    
Day 9    Day 10    
Day 11    Day 12    
Day 13    Day 14    
Day Date Morning 
 
Evening 
 
Day Date Morning 
 
Evening 
 
Day 15    Day 16    
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Date:          
Station: 
Signature of the Investigator: 
 
 
Signature of the Lecturer:                                                              Signature of the HOD 
 
 
 
 
 
 
 
 
 
Day 17    Day 18    
Day 19    Day 20    
Day 21    Day 22    
Day 23    Day 24    
Day 25    Day 26    
Day 27    Day 28    
Day 29    Day 30    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL 
CHENNAI – 600 047. 
POST -  GRADUATE DEPARTMENT OF SIRAPPU MARUTHUVAM 
Preclinical and clinical study on PARANGICHAKKAI CHOORNAM (Internal 
Medicine) and NEERADIMUTHU PASAI (External Medicine) for the treatment of 
PADAR THAMARAI (Pundareega Kuttam) 
                                                                                                                 
FORM IX - ADVERSE REACTION FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:…………………………………    AGE: …… GENDER: ……….. 
DATE OF TRIAL COMMENCEMENT: …………………… 
DESCRIPTION OF ADVERSE REACTION: 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
 
 
